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Summary 
In the nucleus of each cell, the DNA is packed with proteins into chromatin. 
Chromatin consists of DNA wrapped around nucleosomes, which contain two copies of each 
of the four core histones H2A, H2B, H3 and H4. Histones are composed of one core domain 
that is flanked by variable N- and C-terminal tails, which can be modified through different 
posttranslational modifications such as acetylation, methylation, ubiquitylation, 
phosphorylation and (ADP-ribosyl)ation.  
Poly(ADP-ribosyl)ation is catalyzed by poly(ADP-ribose) polymerase 1 (PARP1) 
by covalent attachment of multiple ADP-ribose units, using NAD+ as the substrate. PARP1 
and its enzymatic activity play a crucial role in many physiological and pathophysiological 
processes, such as maintenance of genomic stability through DNA repair, transcriptional 
regulation (e.g. inflammation), cell cycle regulation and cell death through apoptosis or 
necrosis. 
The aim of this thesis was to investigate whether histone tails are (ADP-ribosyl)ated 
by PARP1, PARP2 and PARP10 and furthermore to identify potential ADP-ribose acceptor 
sites of the core histone tails. 
We found that GST-tagged histone tails are indeed trans(ADP-ribosyl)ated by 
PARP1 and GST-PARP10(818-1025), but not by PARP2. Furthermore, the minimal deletion 
mutant required for the interaction with PARP1 was identified for each core histone tail, 
which correlated with the deletion mutant required for (ADP-ribosyl)ation, except for H2B. 
High NaCl concentrations reduced the interaction of PARP1 with the GST-tagged histone 
tails and subsequently also (ADP-ribosyl)ation. Lysines were found to be the most important 
residues for (ADP-ribosyl)ation of the histone tails, since substitution of distinct lysines 
resulted in a loss of (ADP-ribosyl)ation. Possible ADP-ribose acceptor sites modified by 
PARP1 are K13/R20 of H2A as well as K16/20 of H4. Important for the interaction with 
PARP1 are K15/R20 of H2A, R29/31/33 of H2B, R26 of H3 and K16/20 of H4. The histone 
tails mainly interact with the automodification domain of PARP1. Finally, same analyses with 
GST-PARP10(818-1025) suggested possible ADP-ribose acceptor sites modified by PARP10, 
namely K13/15 of H2A, K27/28/30/34/R29/31/33 of H2B and K16/20, R17/19 of H4. 
Together these experiments provide evidence that specific lysine and possibly 
arginine residues of histone tails are (ADP-ribosyl)ated by PARP1 or PARP10. Parts of this 
thesis were recently accepted for publication. 
 
Zusammenfassung  
 
 
6
Zusammenfassung 
 DNA ist im Zellkern in Form von Chromatin kondensiert. Das Chromatin besteht aus DNA, 
die um Nukleosomen gewickelt ist, welche aus jeweils zwei Kopien von jedem Kern-Histon H2A, 
H2B, H3 and H4 zusammengesetzt sind. Histone bestehen aus einer Kern-Domaine, die N- und C-
terminal von einem variablen Ende flankiert wird. Diese Enden können durch verschiedene 
posttranslationelle Modifikationen, wie Acetylierung, Methylierung, Ubiquitylierung, 
Phosphorylierung und (ADP-Ribosyl)ierung verändert werden.  
 Poly(ADP-Ribosyl)ierung wird von Poly(ADP-Ribose) Polymerase 1 (PARP1) durch 
kovalentes anhängen von mehreren ADP-Ribose-Einheiten, mittels Benutzung von NAD+ als Substrat 
katalysiert. PARP1 und seine enzymatische Aktivität spielen eine entscheidende Rolle in vielen 
physiologischen und pathophysiologischen Vorgängen, wie z.B. dem Erhalt der genomischen 
Stabilität durch DNA Reparatur, Regulation der  Transkription (z.B. im Entzündungsgeschehen), 
Regulation des Zellzyklus und Zelltod infolge Apoptose oder Nekrose. 
  Ziel dieser Dissertation war zu erforschen, ob Histonenden durch PARP1, PARP2 oder 
PARP10 (ADP-ribosyl)iert werden, sowie die potentiellen Akzeptoren von ADP-Ribose auf Kern-
Histonenden zu identifizieren. 
 Wir beobachteten dass GST-Histonenden von PARP1 und GST-PARP10(818-1025), aber 
nicht von PARP2 (ADP-ribosyl)iert werden. Weiter wurde die minimal nötige Deletionsmutante für 
erfolgreiche Interaktion der Histonenden mit PARP1 identifiziert. Diese korrelierten mit den 
Deletionsmutanten, die für erfolgreiche (ADP-Ribosyl)ierung nötig sind, mit Ausnahme für H2B. 
Hohe Salzkonzentrationen reduzierten die Interaktion von PARP1 mit den GST-Histonenden und 
deshalb auch die (ADP-Ribosyl)ierung. Wir fanden dass Lysine die wichtigsten Stellen für (ADP-
Ribosyl)ierung von Histonenden sind, da bei einer Substitution von spezifischen Lysinen keine (ADP-
Ribosyl)ierung mehr stattfinden konnte. Mögliche Akzeptoren von PARP1-regulierter (ADP-
Ribosyl)ierung sind K13/R20 von H2A und K16/20 von H4. Wichtig für die Interaktion mit PARP1 
sind K15/R20 von H2A, R29/31/33 von H2B, R26 von H3 und K16/20 von H4. Die Histonenden 
interagieren vor allem mit der Automodifikationsdomäne von PARP1. Schlussendlich haben gleiche 
Untersuchungen mit PARP10 weitere mögliche Akzeptoren von ADP-Ribose aufgedeckt, nämlich 
K13/15 von H2A, K27/28/30/34/R29/31/33 von H2B und K16/20, R17/19 von H4. 
 Zusammen erbringen diese Versuche den Nachweis, dass spezifische Lysine und 
möglicherweise Arginine der Histonenden von PARP1 oder PARP10 (ADP-ribosyl)iert werden. Teile 
dieser Dissertation wurden vor kurzem zur Publikation angenommen. 
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Abbreviations 
aa amino acid 
AD Automodification domain 
AIF Apoptosis-inducing factor 
ATP Adenosine triphosphate 
bp base pairs 
BSA Bovine serum albumine 
CAT Catalytic domain 
DBD DNA-binding domain 
DNA Deoxyribonucleic acid 
dN73¶V deoxy Nucleotide-Tri-Phosphates 
DSB Double strand breaks 
FL Full-length 
GST Glutathione S-transferase 
h human 
H1 Histone 1 
H2A Histone 2A 
H2B Histone 2B 
H3 Histone 3 
H4 Histone 4 
NAD+ Nicotinamide adenine dinucleotide 
PAR Poly(ADP-ribose) polymer 
PARG Poly(ADP-ribose) glycohydrolase 
PARP Poly(ADP-ribose) polymerase 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
RNA Ribonucleic acid 
SDS Sodium-dodecyl-sulfate 
SSB Single strand breaks 
TBS Tris buffered saline 
TBS-T Tris buffered saline Tween 20 
U Unit 
V Volt 
wt wildtype 
ZF Zinc Finger 
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1 Introduction 
1.1  Chromatin 
1.1.1 Introduction 
7KHOHQJWKRID'1$LV¶WLPHVORQJHUWKDQDFHOO7KHUHIRUHWKH'1$KDVWR
be arranged in a special manner in form of the chromatin and chromosomes to scope with the 
size of the cell (1). The chromatin is formed by wrapping DNA around nuclear proteins such 
as histones and non-histone proteins (2, 3). Importantly, the chromatin structure is an obstacle 
for genomic activities such as replication, transcription, recombination or repair. Thus, it is 
important that the DNA is made accessible in response to various stimuli. This is achieved by 
exchanging or chemical modifying histones, which lead to a change of the chromatin structure 
(2). Chromatin can be divided into two states, which are called euchromatin and 
heterochromatin. Euchromatin is less condensed chromatin, which is more accessible for 
proteins regulating cellular processes. Heterochromatin represents the compact state of 
chromatin, which is tightly folded and inaccessible for regulatory proteins. Each of these 
states is associated with a distinct set of histone modifications (4). 
 
1.1.2 Chromatin structure 
The compact chromatin structure comprises three different condensation levels (Fig. 
1). 
Introduction  
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Figure 1:   Multiple levels of chromatin folding. DNA compaction within the interphase nucleus occurs through 
a hierarchy of histone-dependent interactions that can be subdivided into primary, secondary, and 
tertiary levels of structure. Strings of nucleosomes compose the primary structural unit. Formation of 
QP¿EHUVWKURXJKKLVWRQH-tail-mediated nucleosome-nucleosome interactions provides a secondary 
level of compaction, whereas tail-PHGLDWHG DVVRFLDWLRQ RI LQGLYLGXDO ¿EHUV SURGXFHV tertiary 
VWUXFWXUHVVXFKDVFKURPRQHPD¿EHUV (5). 
 
 7KH¿UVWOHYHORIFRQGHQVDWLRQZKLFK generates a 7-fold compaction, is achieved by 
wrapping DNA around histones to form the nucleosome, which has a diameter of 10nm and 
builds the basic unit of the chromatin (2, 6). One nucleosome contains two copies of each of 
the four core histones H2A, H2B, H3 and H4, around which are wrapped one and three-
quarter superhelical turns of DNA (146 bp) (2). Histones are basic proteins containing a large 
number of positive charged amino acids, which enable the interaction with the negatively 
charged DNA. The DNA linker length connecting two nucleosomes is species dependent and 
varies from 15 to 55 base pairs (1). In presence of the linker histone H1, the chromatin 
condenses from the fully extenGHG ³EHDGV RQ D VWULQJ´ FRQ¿JXUDWLRQ LQWR D QP ¿EHU IRU
which six nucleosomes are coiled to form one turn, called solenoid structure (2, 6-8). 
Interactions with additional factors, such as non-histone and nuclear matrix scaffold proteins, 
establish large chromatin loop domains that can be compacted further to generate interphase 
and mitotic chromosomes (2). Chromonema fibers represent the highest ordered state of 
chromatin in vivo (9). 
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1.1.3 Histone proteins 
There are five different histones in mammalian cells which play a role in chromatin 
formation, namely the nucleosomal or core histones H2A, H2B, H3 and H4 as well as the 
linker histone H1 (10). Histones are expressed during S-phase and are incorporated into 
chromatin in a DNA replication-dependent manner. They are composed of one core domain 
that is flanked by two tail domains. The core domains of histones are responsible for 
establishing protein-protein interactions and for the compaction of the DNA (11). The N- and 
C-terminal tail domains can form additional DNA contacts and can be modified by different 
posttranslational modifications such as acetylation, methylation, ubiquitylation, 
phosphorylation and (ADP-ribosyl)ation (2, 7, 12, 13). Posttranslational modifications of the 
tail domains can neutralize the net positive charge of the tails, which reduces the interaction 
with the negative charged phosphate backbone of the DNA. Modified chromatin is therefore 
often less condensated and better accessible for proteins involved in transcription, replication 
and repair (1, 4). 
The histones H3 and H4 form a heterotetramer, representing the core of the 
nucleosome structure that is flanked by two histone H2A and H2B heterodimers. The H3-H4 
tetramer is strongly interacting with the nucleosomal DNA and their N-terminal tail domains 
exit the nucleosome close to the points where the DNA starts to bind or leaves the 
nucleosome (4, 14-16). In contrast to H3 and H4, histones H2A and H2B are weakly 
associated with nucleosomal DNA (17-20) and more frequently displaced from nucleosomes 
(21-27), suggesting that posttranslational modifications on these histones play a less important 
role (14). Similar to the core histones, linker histone H1 can be covalently modified. The best-
studied modification is currently phosphorylation, which weakens the binding of H1 to 
chromatin and thus destabilizes chromatin structure (10). 
 
1.1.4 Histone variants 
Beside remodelling the chromatin by posttranslational modification of histones, 
there is also another way to regulate the chromatin barrier, namely through incorporation of 
histone variants into nucleosomes (28). Histone variants are subtypes of core histones and are 
mainly expressed in other cell cycle phases than the S-phase and incorporated into chromatin 
in a DNA replication-independent manner (29). The histone variants are suggested to be 
Introduction  
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located in novel types of nucleosomes, which are located on the chromatin in addition to 
nucleosomes containing only core histones (30, 31). 
One of the best characterized histone variant is H2A.Z, which is a histone variant of 
histone H2A. The N- and C-terminal domains of H2A.Z have a substantially different 
sequence from that of the core histone H2A (28, 32, 33). H2A.Z is required for one or more 
essential roles that cannot be replaced by H2A (32, 33). Several lines of evidence suggest that 
the incorporation of H2A.Z within chromosomes promotes an actively transcribed chromatin 
state (28, 34, 35). The theory based on experiments with knockout mice suggests that H2A.Z 
is important for stabilizing promoters for gene activation (33, 36, 37). The proposed promoter 
stabilization activity could also be related to the structure of H2A.Z nucleosomes, which 
prevent internucleosomal interactions and therefore promotes a more open chromatin 
conformation, which is characteristic for transcriptionally active genes (28, 38). Other 
variants of H2A are macroH2A, H2A.X and H2ABbd. The function of the variant macroH2A 
is to silence genes. It is found as a component of the inactivated X-chromosome in female 
cells (39). The variant H2A.X is modified by phosphate groups after DNA damage and 
therefore acts as one of the earliest responses to DNA damage by repressing transcription (4, 
29). Finally, the variant H2ABbd activates transcription and is located on active X-
chromosomes and autosomes (29). 
The histone H3 has two histone variants, H3.3 and CENP-A. The variant H3.3 is 
mainly expressed in genetically active chromatin, whereas CENP-A is localized in 
centromere-regions of chromosomes (39). Comparable to the core histones, there are also 
linker histone variants that are nonrandomly incorporated into chromatin and expressed in cell 
type-specific patterns (40). 
Accumulating evidence suggests WKDW WKH FRPELQDWLRQ RI PRGL¿FDWLRQV RQ
nucleosomes including core histones and various histone variants, contribute to the epigenetic 
information, the ultimate regulation of gene expression (41). Epigenetics is defined as 
heritable changes in the genome function that occurs without alterations of the DNA sequence 
(42). Therefore, the study of histone proteins and of their posttranslational modifications, has 
become increasingly important as more LQYHVWLJDWLRQV DUH FRQGXFWHG LQWR WKH ³HSLJHQHWLF
VLJQDWXUHV´of these important chromosomal proteins (43). 
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1.1.5 Non-histone proteins 
Chromatin-associated non-histone proteins form one-third of the mass of mitotic 
chromosomes and remain associated with the chromatin, even after removal of the histones 
(3). Many different proteins belong to the group of non-histone proteins, such as high 
mobility group (HMG) proteins, scaffold proteins, DNA topoisomerases and DNA 
polymerases, all regulating different functions (8). One important function is the maintenance 
of the chromosomal structure (8). Additionally chromosomal non-histone proteins play a role 
in three important aspects of mitotic events, such as (i) chromosome condensation, (ii) sister 
chromatid separation and (iii) interaction of the chromosomes with the cytoskeleton during 
formation of the mitotic spindle (3). 
 
1.2  Posttranslational modifications 
1.2.1 Introduction 
Posttranslational modifications are reversible modifications of proteins through an 
enzymatic attachment of special chemical groups, which regulate the biological activity 
(structure and function) of the modified proteins (8). Different modifications have been 
described for histones so far, namely: acetylation, methylation, phosphorylation, 
ubiquitylation, sumoylation, (ADP-ribosyl)ation, deimination and proline isomerization (4). 
Modifications on histones are usually reversible (4). The vast array of posttranslational 
modifications provides enormous potential for the regulation of functional responses within 
the cell (4) and belongs to the mechanisms that define epigenetics (44).  
 
1.2.2 Impact of posttranslational histone modifications on the chromatin 
Histones can be modified at over 60 different amino acid residues on their N-
terminal tails (4), whereas H3 has the greatest number of currently reported modifications, 
followed by H4, H2B and H2A. The C-terminal tails also contain posttranslational 
modifications, but to a lesser extent when compared to the N-terminus (44). Two 
characteristic alterations are known to be induced by histone modifications. The first 
alteration is the disruption of contacts between two nucleosomes or between a nucleosome 
and the DNA, in order to unfold chromatin (4). Acetylation has the highest potential to unfold 
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chromatin, since it neutralizes the positive charge of the lysines. Therefore actively 
transcribed euchromatin usually contains high levels of histone acetylation, whereas silent 
heterochromatin is associated with low levels of histone acetylation (4). The second alteration 
is the modification-dependent recruitment of non-histone proteins (e.g. remodelling 
ATPases), which can further modify or alter the chromatin structure through their enzymatic 
activities. The requirement to recruit an ordered series of enzymatic activities can be 
explained by the fact that regulatory processes such as transcription, replication and repair are 
subdivided in several steps. Each one of these steps may require a distinct type of chromatin-
remodelling activity and a different set of modifications (4). 
Most of the known modifications were identified while studying transcription and 
can be divided into two groups, those that activate transcription and those that repress 
transcription. Transcriptional activation is accompanied by acetylation, methylation, 
phosphorylation or ubiquitylation, and transcriptional repression by methylation, 
ubiquitylation, sumoylation, deimination or proline isomerization. Thus, any given 
modification has the potential to activate or repress gene expression depending on the 
modified residue and the context (e.g. other modifications) (4).  
Chromatin also generates a barrier for the repair of damaged DNA. Therefore 
modifications on histones are also required to facilitate the recognition and the accessibility of 
sites where DNA needs to be repaired. One of the earliest response to DNA damage in 
mammalian cells is the phosphorylation of the histone variant H2A.X. Beside 
phosphorylation, also ubiquitylation, methylation and acetylation of lysines play a role in 
DNA repair (4). Condensation and decondensation of chromatin are important processes 
during the replicative cell cycle. This function is regulated by phosphorylation and acetylation 
of histones (4). 
 
1.2.3 Cross-talk of posttranslational modifications on histones 
The main targets of posttranslational modifications on histones are lysines and 
arginines. Acetylation on histone tails occur at K5 of H2A, K12/15 of H2B, K9/14/18/23/56 
of H3 and K5/8/12/16 of H4. Histone H3 and H4 can also be methylated on lysines 
K4/9/27/36/79 of H3 and K20 of H4 as well as arginines R2/8/17/26 of H3 and R3 of H4 (4). 
Differential modification of the same lysine residue of the histone tails, makes a cross-talk 
between modifications very likely. The cross-talk might mechanistically occur at several 
levels. Firstly, many different modifications occur on the same lysine residues. This will 
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undoubtedly result in some form of antagonism since distinct types of modifications on 
lysines are mutually exclusive. Secondly, the binding of a protein could be disrupted by an 
adjacent modification. The best example is the phosphorylation of H3S10 affecting the 
binding of HP1 to methylated H3K9 (4, 45). Thirdly, the catalytic activity of an enzyme could 
be compromised by modification of its substrate recognition site; for example, isomerization 
of H3P38 affects methylation of H3K36 by Set2 (4, 46). Fourthly, an enzyme could recognize 
its substrate more effectively in the context of a second modification; the example here is the 
GCN5 acetyltransferase, which may recognize H3 more effectively when it is phosphorylated 
at H3S10 (4, 47). Finally, a cross-talk could also be observed, when the modifications are on 
different histone tails of adjacent histones in an octamer (4). 
 
1.3 Poly(ADP-ribose) polymerases 
1.3.1 Introduction 
Mammalian Poly(ADP-ribose) polymerase 1 (PARP1), is a 113kDa nuclear 
chromatin-associated multifunctional enzyme (48). PARP1 catalyzes the covalent transfer of 
ADP-ribose units from its substrate nicotinamide adenine dinucleotide (NAD+) to itself and/or 
other nuclear proteins (49). Through its physical association with, or by poly(ADP-ribosyl)ing 
target proteins, PARP1 can regulate the chromatin structure and subsequently DNA 
metabolism. These target proteins include histones, high mobility group (HMG) proteins, 
topoisomerases I and II, DNA helicases, single strand break repair and base excision repair 
factors, as well as various transcription factors (50). PARP1 also functions as a survival factor 
for the maintenance of genomic integrity through recognition and signalling of single strand 
breaks (SSB) and double strand breaks (DSB) (51-53). 
 
1.3.2 The PARP family 
PARP1 is the first and best characterized (ADP-ribosyl)transferase member of a 
family consisting of 17 mammalian proteins with a sequence homology to the catalytic 
domain of bacterial Diphteria toxin (48, 54-56). Based on the high sequence similarities of 
their catalytic domains, the 17 mammalian proteins were named PARP1-17 (55, 56). It has 
been suggested that the PARP family can be subdivided into two groups, due to the results of 
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sequence alignments and superpositions of their crystal structures (54). The first group 
contains 6 PARPs, namely PARP1, PARP2, PARP3, PARP4, PARP5a and PARP5b, and is 
characterized by the presence of a glutamate in the active site (54, 56). This glutamate (E988 
in hPARP1) has been reported to be required for ADP-ribose chain elongation catalyzed by 
PARP1 (57, 58). Therefore most PARPs in this group are able to catalyze bona fide polymers 
of ADP-ribose. The second group contains the other 11 PARPs, namely PARP6 to PARP16, 
which lack the corresponding glutamate in their active site (E988 in hPARP1). These 
members may thus rather possess mono(ADP-ribosyl)transferase activity than poly(ADP-
ribosyl)transferase activity or are even inactive (54, 56). The PARP family members can 
additionally be classified according to their putative functional domains or established 
functions, into DNA-dependent PARPs, Tankyrases, CCCH-type PARPs as well as 
macroPARPs (Fig. 2) (50).  
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Figure 2:   The domain architecture of the 17 members of the poly(ADP-ribose) polymerase (PARP) superfamily 
and of poly(ADP-ribose) glycohydrolase (PARG). Protein domains that are illustrated by coloured 
boxes were defined according to the Pfam 19.0 or CCD v2.06 (National Center for Biotechnology 
Information) databases (50). 
 
1.3.3 Structure of PARP1  
PARP1 consists of three functionally distinct domains: a N-terminal DNA-binding 
domain (DBD), an automodification domain (AD) and a C-terminal domain that includes the 
catalytic domain (CAT) responsible for poly(ADP-ribose) (PAR) formation (59, 60). 
The DNA-binding domain (DBD) contains two structurally and functionally unique 
zinc fingers (ZFI: amino acid 11-89; ZFII: amino acid 115-199) (54, 60, 61). Recently, a third 
zinc-binding motif (ZBDIII) was discovered from amino acid 233-373 (62, 63). The PARP1 
ZFI and ZFII are thought to recognize altered structures in the DNA and are also involved in 
protein-protein interactions (60, 64). Several studies indicate that ZFI is required for PARP1 
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activation by DNA single and double strand breaks, whereas ZFII activates PARP1 only by 
DNA single strand breaks (54, 60, 61). ZFI is absolutely required for DNA-dependent 
activation of PARP1, whereas ZFII is dispensable. ZBDIII is essential for the interaction of 
the DBD with the CAT domain and thus for the activation of PARP1 (60). The DBD also 
contains a bipartite nuclear localization signal (NLS), between ZFII and ZBDIII, that targets 
PARP1 to the nucleus (65) and two helix-turn-helix motifs which probably play a role for 
DNA binding (54, 61).  
 
 
 
Figure 3:  Structure of human PARP1 (60). Different domains are explained in the text. 
 
The automodification domain (AD) of PARP1 is located in the central region of the 
enzyme (amino acid 373-525) (66, 67) and contains the acceptor amino acids for the covalent 
attachment of PAR (50). The AD of PARP1 includes a breast cancer 1 protein (BRCA1) C-
terminus (BRCT) domain (54), which is found in many proteins acting in DNA repair or cell 
cycle checkpoint (68). The N-terminal half of the PARP1 AD contains a leucine-zipper motif, 
which is suggested to be involved in homo- and/or heterodimerization with other nuclear 
leucine-zipper proteins (69-75). Next to the AD of PARP1 is an 80-90 amino acid long 
tryptophane-, glycine-, arginine-rich (WGR) domain, which may function as nucleic-acid-
binding domain (54, 60). This region has not yet been extensively characterized. But from 
recent studies, it is known that it is essential for the enzymatic activity of PARP1, although it 
is not necessary for the interaction between the DBD and the CAT domain (60). 
The catalytic domain (CAT) is located at the C-terminal end of PARP1 and 
catalyzes PAR (59, 60). The WGR/CAT domain in PARP1 cooperates tightly with the N-
terminal domain and thus limits the poly(ADP-ribosyl)ation capacity and the ability for 
automodification (60). Only an intact DBD can interact with the CAT domain in a DNA-
dependent manner and induce PAR formation. PAR formation can only take place when ZFI, 
ZBDIII and the WGR domain are present. Otherwise PARP1 is enzymatic inactive (60). 
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1.3.4 Enzymatic activity of PARP1 
Poly(ADP-ribosyl)ation plays an important role in a wide range of physiological and 
pathophysiological processes, such as maintenance of genomic stability, transcriptional 
regulation, centromere function, telomere dynamics and mitotic spindle formation during cell 
division, energy metabolism and cell death (48). In unstimulated cells the levels of PAR are 
usually very low (48, 61, 76). However, in response to genotoxic stress or mitogenic stimuli, 
the PARP activity and the levels of PAR increase 10 to 500 folds (48, 77-80). 
 
1.3.4.1 The poly(ADP-ribosyl)ation reaction 
Poly(ADP-ribosyl)ation is a covalent posttranslational modi¿cation unique to and 
remarkably conserved among metazoans, with exception of yeast, which lack PARPs (2, 61). 
PARPs catalyze the covalent attachment of multiple ADP-ribose units to itself and to a variety 
of target proteins, using NAD+ as the substrate and releasing nicotinamide (2, 81). PAR is a 
homopolymer of ADP-ULERVHXQLWV OLQNHGE\ JO\FRVLGLF´Æ ¶ERQGV EHWZHHQ WKH ULERVH
units (81, 82). The synthesis of PAR requires three distinct enzymatic activities, namely (i) 
the initiation or mono(ADP-ribosyl)ation of the substrate, (ii) the elongation of the polymer 
and (iii) the branching of the polymer (59-61) (Fig. 4).  
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Figure 4:   Poly(ADP-ribose) metabolism. Steps 1 to 3 and 4 to 7 represent the anabolic and catabolic reactions, 
respectively, in the metabolism of PAR. The synthesis of PAR consists of three distinct PARP 
activities: 1) initiation or mono(ADP-ribosyl)ation of specific residues in the acceptor chain, 2) 
elongation of the polymer, 3) branching of the polymer. Figure adapted from (54).  
 
The chain length of polymers is heterogeneous and can reach in vitro 200 units. 
Long polymers are subsequently branched in an irregular manner with a frequency of 
approximately one branch per linear section of 20-50 units of ADP-riboses (83-85). In the 
absence of DNA damage the majority of the ADP-ribose units on the acceptor proteins are 
mono- or oligo(ADP-ribosyl)ated (86, 87). In the presence of DNA strand breaks, the PARP1 
activity as well as the levels of PAR are increased, while cellular NAD+ levels are 
correspondingly reduced (88-90). 
 
1.3.4.2 Catabolism of poly(ADP-ribose) 
Poly(ADP-ribose) has a short half-life and is degraded by the activity of poly(ADP-
ribose) glycohydrolase (PARG), which is activated by increasing cellular concentrations of 
PAR. PARG has an endo- and exoglycosidic activity that cleaves the glycosidic bonds 
between the ADP-ribose subunits, generating free ADP-ribose units and polymers of ADP-
ribose (see Fig. 4). A free ADP-ribose terminus can be further cleaved by PARG or re-
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extended by PARP1 (2). The most proximal ADP-ribose unit is suggested to be released from 
the acceptor protein by either PARG (91) or a ADP-ribosyl protein lyase (92).  
 
1.3.5 Acceptor sites of poly(ADP-ribose) 
Ogata et al. reported in 1980 that glutamic acid residues of histone H1 and histone 
H2B function as ADP-ribose acceptor sites. Additionally glutamic acid residues present in the 
AD of PARP1 were consequently proposed to be acceptor sites for PARP1-mediated 
auto(ADP-ribosyl)ation (50, 60). Despite intensive research, the acceptor amino acids in 
PARP1 have not been confirmed by mutational studies, until 2009. Amino acid substitutions 
established that not glutamic acid residues within the AD of PARP1 are required for PAR 
formation but rather lysine residues within this domain are acceptor sites for (ADP-
ribosyl)ation (60).  
 
1.3.6 (ADP-ribosyl)ation of histones 
 Histones have long been known as substrates for (ADP-ribosyl)ation in vivo (93). 
Histones isolated from rat liver nuclei and HeLa cells incubated with radioactive NAD+ 
revealed that the linker histone H1 and all core histones H2A, H2B, H3 and H4, are (ADP-
ribosyl)ated, although to a variable extent (94-99). However, an unresolved issue regarding 
the mechanism of (ADP-ribosyl)ation of histones is, whether this modification primarily 
occurs at the globular histone domains or at their unstructured amino-terminal tails and which 
PARP family member is responsible for histone (ADP-ribosyl)ation. Unconfirmed ADP-
ribose acceptor amino acids have previously only been proposed for H1 and H2B, but not for 
H2A, H3 and H4 (97, 99-102). (ADP-ribosyl)ation of histones has been detected during the 
cell cycle, replication, transcription and DNA repair (88, 103-114). 
 
1.3.7 Cellular functions of PARP1 
PARP1 was reported to play a crucial role in many physiological and 
pathophysiological processes including inter- and intracellular signalling, cell cycle 
regulation, chromatin remodelling, DNA replication, transcription, DNA repair, V(D)J 
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proteins lost in vitro their affinity to DNA and might therefore increase the DNA accessibility 
for the base excision repair (BER) complex (2). 
 
1.3.7.3   Role of PARP1 in cell death 
There are two models how PARP1 regulates cell death. The first model proposed by 
N. Berger in 1983, suggested that extensive oxidative stress induces overactivation of PARP1 
and moreover leads to depletion of the cellular NAD+ concentrations and subsequently of the 
ATP levels (48, 130, 131). The physiological consequence of NAD+ and ATP depletion 
causes a switch from apoptosis to necrosis (132, 133). This cellular suicide mechanism has 
been implicated in the pathomechanisms of neurodegenerative disorders, cardiovascular 
dysfunction and various other forms of inflammation (48, 134). Interestingly, the contribution 
of poly(ADP-ribosyl)ation reactions to necrotic cell death seems to be dependent on the cell 
type and cellular metabolic status (48). According to genetic studies with PARP1 knockout 
mice, there is evidence that energy depletion alone, as suggested in the first model, might not 
be sufficient to mediate poly(ADP-ribosyl)ation-dependent cell death (135). 
The second model suggests that overactivation of PARP1 through genotoxic stress, 
induces the translocation of apoptosis-inducing factor (AIF) from the mitochondria to the 
nucleus. This causes DNA condensation, fragmentation and subsequently cell death (48). It 
has been reported that AIF participates in both caspase-dependent and -independent cell death 
(136-139).  
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1.4 Aim of the thesis 
The aim of this thesis was to investigate whether histone tails are (ADP-ribosyl)ated by 
PARP1, PARP2 and PARP10 and furthermore to identify potential ADP-ribose acceptor sites 
of the core histone tails. Recent findings reported by Altmeyer et al. provided evidence that 
lysine residues within the AD of PARP1 function as ADP-ribose acceptor sites (60). This led 
to the question whether lysines in histone tails would function as acceptors for PAR as well, 
although glutamates were previously suggested as acceptor sites for core histone H2B and 
linker histone H1 (97, 100). 
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2 Results 
2.1 Core histone tails are (ADP-ribosyl)ated by PARP1 and 
PARP10, but not by PARP2 
Although it was earlier reported that histones can be (ADP-ribosyl)ated, the ADP-ribose 
acceptor sites were not identified so far. To investigate whether histone tails can be (ADP-
ribosyl)ated by PARP1, PARP2 and GST-PARP10(818-1025), histone tails were cloned into 
pGEX-2T vectors and expressed as GST-fusion proteins in bacteria. The GST-tagged histone 
tails comprised following amino acid sequences: 
 
A 
 
 
B 
 
Figure 5: A: Amino acid sequences of human core histone tails, tagged with GST. The most important amino 
acids are colored: K=Lysine, R=Arginine, E=Glutamate. 
  B: Coomassie stained gel of purified GST-tagged core histone tails. GST was loaded as control. 
    MWM= Molecular Weight Marker 
 
Purified GST-tagged histone tails were incubated in presence of 100nM 32P-NAD+, 
either with purified PARP1 and PARP2 both expressed and purified from baculo virus or with 
GST-PARP10(aa:818-1025 = CAT domain) expressed and purified from bacteria. The 
reaction was stopped and proteins separated by 12% SDS-PAGE. After Coomassie staining, 
the gels were vacuum dried and exposed to a Phosphor screen to quantify the incorporated 
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radioactivity, which would correlate with (ADP-ribosyl)ation of the GST-tagged histone tails 
(Fig. 6). 
 
 
 
Figure 6:  The upper panels show the Phosphor Image of the gels for quantification of radioactivity and the 
lower panels show Coomassie stained gels for quantification of the protein levels. MWM = 
Molecular Weight Marker 
 
PARP1 was able to (ADP-ribosyl)ate itself and trans(ADP-ribosyl)ate all cloned core 
histone tails, although H2A was stronger modified than H2B, H3 and H4 under the tested 
conditions. PARP2 was also able to efficiently (ADP-ribosyl)ate itself, but in contrast to 
PARP1, it was not able to trans(ADP-ribosyl)ate the tested histone tails. In contrast to 
PARP2, GST-PARP10(818-1025) was able to (ADP-ribosyl)ate itself as well as trans(ADP-
ribosyl)ate the analyzed histone tails, with the same preference as observed for PARP1. 
Surprisingly, GST-PARP10(818-1025) also weakly (ADP-ribosyl)ated GST alone (negative 
control), suggesting that the observed trans(ADP-ribosyl)ation of the GST-tagged H3 tail 
might just be background labelling. This experiment strongly indicates that all tested core 
histone tails are trans(ADP-ribosyl)ated by PARP1 and the CAT domain of GST-PARP10 
(with the exception of H3), but not by PARP2. Glutamic acid residues were earlier suggested 
to be ADP-ribose acceptor residues (97, 100). Interestingly, none of the tested GST-tagged 
histone tails contained a glutamic acid residue except for H2B (E2), indicating that other 
amino acid residues could function as ADP-ribose acceptor sites. 
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2.2 Optimization of histone tail trans(ADP-ribosyl)ation 
The (ADP-ribosyl)ation reactions were performed so far without NaCl, since the added 
PARPs contained already NaCl (usually 14-20mM of NaCl). To determine the optimal NaCl 
concentration, (ADP-ribosyl)ation of GST-tagged H4 tails by PARP1 in presence of 100nM 
32P-NAD+ and increasing salt concentrations was performed. Six different NaCl 
concentrations from 0 to 150mM NaCl were tested. The reaction was stopped and the proteins 
separated by 12% SDS-PAGE. After gel electrophoresis, the gel was stained with Coomassie, 
vacuum dried and the incorporated radioactivity again quantified by Phosphor screen (Fig. 7). 
 
   
Figure 7:  Phosphor Image of the gel to quantify (ADP-ribosyl)ation of GST-tagged H4 tail with different NaCl 
concentrations. 
 
Complete loss of H4 tail trans(ADP-ribosyl)ation was observed at 100mM NaCl, 
although a clear reduction of (ADP-ribosyl)ation was already observed at 25mM NaCl. These 
results indicate that the NaCl concentration either inhibits directly the enzymatic activity of 
PARP1 or reduces the interaction of PARP1 with the histone tails (see also 2.5). Further 
assays were subsequently performed without additional NaCl, only containing the NaCl added 
with PARP1 (approx. 20mM). 
To determine the optimal incubation time for PARP1-mediated trans(ADP-ribosyl)ation, 
an (ADP-ribosyl)ation assay (described in Materials and Methods, 4.2.4) with GST-tagged H3 
tail at 30°C and different incubation times was performed. The reaction was stopped at the 
different indicated time points (see Fig. 8, A) and proteins separated by 12% SDS-PAGE. 
After gel electrophoresis, the gel was stained with Coomassie, vacuum dried and radioactivity 
quantified by Phosphor screen (Fig. 8). 
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A 
 
B 
 
 
Figure 8:   A: Phosphor Image of the gel to quantify (ADP-ribosyl)ation with different incubation times of 
PARP1. 
  B:  Time course representing the intensity of (ADP-ribosyl)ation from Phosphor Image in A. 
 
This experiment revealed that (ADP-ribosyl)ation of GST-tagged H3 tail was increasing 
over a time period reaching a maximum after 20 minutes. Longer incubation did not further 
increase the incorporated radioactivity, suggesting that the optimal incubation time under the 
tested conditions was less than 20 minutes. Earlier publications reported that (ADP-
ribosyl)ation can also take place in a non-enzymatic manner through Schiffbase formation. To 
reduce the possibility of non-enzymatic (ADP-ribosyl)ation of the histone tails, and to 
measure (ADP-ribosyl)ation in a linear range, subsequent (ADP-ribosyl)ation assays with 
PARP1 were performed as before with an incubation time of 5 minutes. 
 
2.3 Identification of the minimal histone tail deletion mutant 
required for PARP1 interaction 
To localize the PARP1 interaction and possible ADP-ribose acceptor sites on the histone 
tails, deletion mutants of the GST-tagged core histone tails were generated. Since Altmeyer et 
al. recently reported that specific lysine residues in the automodification domain of PARP1 
are acceptor amino acids of ADP-ribose (60), different deletions of the core histone tails were 
constructed always ending two amino acids after a certain lysine (Fig. 9). 
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A 
 
 
B 
 
C 
 
D 
 
Figure 10: Interaction analyses to identify minimal deletion mutants required for PARP1 interaction. A: H2A,  
B: H2B, C: H3, D: H4. The upper panels are western blot analyses using an anti-PARP1 antibody. 
PARP1 was used as positive control (lane 1) and GST as negative control (lane 2). The lower panels 
show Coomassie stained PVDF membranes to quantify the GST-tagged protein levels. MWM = 
Molecular Weight Marker 
 
 PARP1 bound to all tested full-length GST-tagged histone tails (Fig. 10, A-C). 
Interestingly, interaction with PARP1 was lost for each GST-tagged histone tail with a 
distinct deletion mutant. The minimal deletion mutants required for interaction with PARP1 
are D2 for H2A, D1 for H2B, D2 for H3 and D2 for H4. This experiment indicates that the 
interaction sites are located at the end of each deletion mutant. The reduced level of PARP1 
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bound to H2A-D2 is probably due to lower loaded histone tail input as judged by the 
Coomassie stained PVDF membrane (Fig. 10, A). 
 
2.4 PARP1/Histone tail interaction regulates (ADP-ribosyl)ation 
of histone tails 
To investigate whether the minimal deletion mutants of the GST-tagged histone tails 
required for the interaction with PARP1 would correlate with the ability to be (ADP-
ribosyl)ated, the different mutants were modified by PARP1 in presence of 100nM 32P-NAD+. 
The reaction was stopped and the histone tail deletion mutants subsequently separated by 12% 
SDS-PAGE. The gels were stained with Coomassie to visualize the proteins and then exposed 
to X-ray films or to a Phosphor screen to detect and quantify the incorporated radioactivity.  
Loss of (ADP-ribosyl)ation was observed for the same deletion mutants, which would not 
anymore interact with PARP1, indicating that the loss of (ADP-ribosyl)ation is due to lack of 
interaction (Fig. 11). Only the H2B tail deletions reacted differently. The minimal deletion 
mutant required for the interaction, was not longer (ADP-ribosyl)ated. Only the full-length 
H2B tail was (ADP-ribosyl)ated by PARP1, although D1 was still interacting, indicating that 
the interaction and modification site is not correlating for the H2B tail. Interestingly, H2A-D2 
was only modified to 40%, despite the fact that this deletion was still interacting, suggesting 
that additional modification sites would be located in the sequence covered by D1. 
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Figure 11:  Result of the interaction assay in comparison to the result of (ADP-ribosyl)ation (%) of the histone tail 
deletions. 
  Minimal deletion mutants required for the interaction, full interaction, no interaction 
   = indicates location of possible ADP-ribose acceptor sites 
   = indicates location of possible PARP1 interaction sites 
   
2.5 PARP1/Histone tail interaction is of an electrostatic nature 
To strengthen the interaction assay and to analyze if the observed inhibitory effect of 
NaCl on the enzymatic activity of PARP1 (see chapter 2.2), could be due to an abolished 
interaction of PARP1 with the GST-tagged histone tails, PARP1 interaction assays with H4 
deletions and increasing NaCl concentrations were repeated. GST-tagged histone tail 
deletions of H4 were bound from bacterial crude extracts to glutathione-beads, washed three 
times with EBC-buffer and subsequently two times with (ADP-ribosyl)ation-buffer 
containing three different NaCl concentrations (as indicated in Fig. 12). The different NaCl 
concentrations were not only used to wash the beads, but were also included for the 
interaction reaction together with 10pmol of PARP1. After 2 hours incubation, beads were 
washed again with (ADP-ribosyl)ation-buffer and the indicated NaCl concentration. Bound 
proteins were eluted from the beads with 10mM glutathione and 200mM NaCl. The eluted 
samples were boiled at 95°C and separated by 12% SDS-PAGE. After gel electrophoresis the 
proteins were blotted onto a PVDF membrane and analyzed by western blot using an anti-
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PARP1 antibody to detect the interaction of PARP1 with H4 deletions. PARP1 was visualized 
using enhanced chemiluminescence (Fig. 12). Purified PARP1 was loaded as positive control 
in the first lane. 
 
Figure 12: The upper panels are western blot analyses using an anti-PARP1 antibody. PARP1 was used as   
positive control (lane 1). The lower panels show Coomassie stained PVDF membranes to quantify the 
protein levels. MWM = Molecular Weight Marker 
 
PARP1 interacted with the tested GST-tagged histone tails in absence of exogenous salt 
as observed before. As soon as the salt concentration was increased to 100mM NaCl the 
interaction of PARP1 with H4-D1 was reduced, in comparison to H4-wt. No interaction could 
be detected at the same NaCl concentration with H4-D2 or a shorter deletion as observed 
before (Fig. 10, D). Overall, these assays provide evidence that NaCl is indeed affecting the 
interaction of PARP1 with the GST-tagged histone tails, suggesting that the PARP1/histone 
tail interaction is of an electrostatic nature. The remaining binding of PARP1 to H4-wt at 
100mM NaCl furthermore indicated, that amino acid residues at the very C-terminus of the 
tail might additionally stabilize the interaction with PARP1. High NaCl concentrations 
consequently inhibited (ADP-ribosyl)ation. Based on this result, subsequent interaction assays 
were performed in presence of 50mM NaCl to increase the stringency. 
 
2.6 Lysine replacement in the H3 tail results in a loss of 
trans(ADP-ribosyl)ation by PARP1 
To precisely locate the ADP-ribose acceptor sites within the histone tails, several lysine 
residues were mutated in the full-length context of GST-tagged H3 tail. Since lysines were 
recently suggested to be the ADP-ribose acceptor sites by our laboratory, we assumed that a 
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mutation of lysine residues would cause a loss of (ADP-ribosyl)ation. Five lysine residues 
(K9, K14, K18, K23 and K27) of the GST-tagged H3 tail were mutated into alanine residues 
by overlapping PCR (as indicated in Materials and Methods, 4.1.1). The H3 KA mutant 
contained all five lysine to alanine substitutions. To analyze whether the H3 tail mutants 
would still be trans(ADP-ribosyl)ated, a PARP1-mediated (ADP-ribosyl)ation assay in 
presence of 100nM 32P-NAD+ was performed. The reaction was stopped after 5min and 
proteins were separated by 12% SDS-PAGE. After Coomassie staining, the gel was vacuum 
dried and exposed to a Phosphor screen to quantify the incorporated radioactivity (Fig. 13). 
              
 Figure 13: Phosphor Image of the gel to quantify (ADP-ribosyl)ation of different H3 mutations. 
 
None of the single tested mutants showed a loss of (ADP-ribosyl)ation, although some 
mutations like K14A and K23A showed a slight reduction of (ADP-ribosyl)ation. However, 
this reduction of (ADP-ribosyl)ation of single or double substitutions could not further be 
confirmed. Only the H3 KA mutant of the GST-tagged H3 tail was not longer (ADP-
ribosyl)ated by PARP1, assuming that lysines are indeed ADP-ribose acceptor sites. 
 
2.7 Addition of DNA does not influence the interaction of PARP1 
with GST-tagged histone tails 
To analyze whether addition of DNA would affect the interaction of PARP1 with the 
GST-tagged histone tails, a PARP1 interaction assay in presence or absence of DNA was 
performed. For this purpose 10pmol of DNA-free PARP1 (purified with Ethidiumbromide to 
remove co-purified DNA) with or without 5pmol DNA was added to the minimal deletion 
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mutant of each histone tail bound on beads and incubated for 2 hours. After removing 
unbound PARP1, beads were boiled and proteins separated by 12% SDS-PAGE. After gel 
electrophoresis, proteins were blotted from the gel onto a PVDF membrane and analyzed by 
western blot using an anti-PARP1 antibody to detect interacting PARP1. The presence of 
PARP1 was visualized using enhanced chemiluminescence (Fig. 14). 
            
Figure 14: The upper panel shows the western blot analysis using an anti-PARP1 antibody. The lower panel 
shows a Coomassie stained PVDF membrane to quantify protein levels of PARP and histone tails.  
 MWM = Molecular Weight Marker 
 
PARP1 was interacting with all four tested histone tails independent whether DNA was 
present or not, indicating that DNA has no impact on the interaction of PARP1 with GST-
tagged histone tails. Thus the DNA was omitted for all further interaction experiments. 
 
2.8 Identification of ADP-ribose acceptor sites in histone tails 
modified by PARP1  
To extend the analyses also including the other histone tails, different K to A 
substitutions were generated by overlapping PCR (as described in Materials and Methods, 
4.1.1) in the full-length context or in the minimal interaction mutants of the histone tails and 
subsequently tested for (ADP-ribosyl)ation and interaction with PARP1. Since arginine 
residues could potentially also be important for (ADP-ribosyl)ation or interaction, also 
arginine to alanine substitutions were generated for the different constructs. All generated 
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mutations were expressed in bacteria, purified and then first tested in PARP1-mediated (ADP-
ribosyl)ation assays, to identify substitutions, which are not longer (ADP-ribosyl)ated and 
would therefore point at possible ADP-ribose acceptor sites. The histone tail mutations were 
incubated with PARP1 in presence of 100nM 32P-NAD+ for 5min at 30°C. The reaction was 
stopped and the histone tail mutations subsequently separated by 12% SDS-PAGE. The gels 
were stained with Coomassie to visualize proteins and then exposed to X-ray films or to a 
Phosphor screen to detect and quantify the incorporated radioactivity. The (ADP-ribosyl)ation 
results are summarized in 2.8.1-2.8.4 (Tables 1-4). While several mutants of H2A and H4 
were not any longer (ADP-ribosyl)ated by PARP1 (Table 1,4), only one distinct mutant of 
H2B or H3 was not longer modified (Table 2,3). To elucidate whether the reduced or missing 
histone (ADP-ribosyl)ation was due to an inhibited interaction with PARP1, interaction 
assays with the GST-tagged histone tail deletions and mutations were performed. Histone tail 
deletions and the available mutations or GST alone (negative control) were bound from 
bacterial crude extracts to glutathione-beads. The beads were washed five times with two 
buffers and subsequently incubated with 10pmol of PARP1 without addition of DNA or 
NAD+. After 2 hours incubation time, beads were washed three times to remove unbound 
PARP1. The beads were boiled and loaded on a 12% SDS-PAGE to separate proteins. After 
gel electrophoresis, proteins were blotted onto a PVDF membrane and analyzed by western 
blot using an anti-PARP1 antibody to detect a possible interaction with PARP1. Purified 
PARP1 was loaded as positive control in the first lane. Beads loaded with GST and incubated 
with PARP1 were used as negative control and loaded in the second lane. The presence of 
PARP1 was visualized using enhanced chemiluminescence (see following figures). 
 
2.8.1 K13/R20 of H2A are possible acceptor sites and K15/R20 are 
important for the interaction with PARP1 
Interaction assays with H2A tail deletions and mutations confirmed earlier results, 
that the interaction of H2A with PARP1 is abolished when using D3 (Fig. 10A and 15). 
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Figure 15: The upper panel is a western blot analysis using an anti-PARP1 antibody. PARP1 was used as 
positive control (lane 1). The lower panel shows a Coomassie stained PVDF membrane to quantify 
the protein levels of the H2A tails. MWM = Molecular Weight Marker 
 
 In the H2A-D1 context a loss of interaction was observed when K15 and R20 were 
substituted to alanines and also when K13 and K15 together with R20 were substituted to 
alanines. Since substitution of R20 alone was not sufficient to abrogate the interaction, either 
the combination of K15 with R20 or K15 alone would be responsible for the interaction of the 
H2A tail with PARP1. The level of bound PARP1 was reduced when K13 and K15 were both 
substituted to alanines, which was, however, probably due to the lower loaded protein input as 
judged by the Coomassie stained PVDF membrane. This experiment revealed that the H2A 
tail interacts with PARP1 through K15 and R20. 
 By comparing these interaction results with the (ADP-ribosyl)ation results, possible 
acceptor sites were identified for H2A (Table 1). 
 In the full-length context of H2A a 50% reduction of (ADP-ribosyl)ation was 
observed when both, K13 and K15, were substituted to alanines. Since this mutant was still 
interacting with PARP1, these two lysines are indeed possible ADP-ribose acceptor sites. 
Substitution of R20 alone even showed a higher reduction (80%) of (ADP-ribosyl)ation, 
although full interaction was observed, suggesting that R20 as well is a possible acceptor site. 
The combination of K13/R20 reduced (ADP-ribosyl)ation completely, confirming that these 
two residues are the most important residues for modification in the H2A-D1 context, and that 
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K15 is most probably not modified but important together with R20 for the interaction of the 
H2A tail with PARP1. 
       
Table 1: Percentage of (ADP-ribosyl)ation and result of the interaction assay for H2A tail. Red labelled are the 
possible ADP-ribose acceptor sites.  
             
2.8.2 R29/31/33 are important for the interaction of H2B with PARP1 
Interaction assays with H2B tail deletions and mutations confirmed earlier results, 
that the interaction of H2B with PARP1 is abolished when using D2 but not when using D1 as 
observed for trans(ADP-ribosyl)ation (Fig.10B and 16). 
 
 
Figure 16: The upper panel is a western blot analysis using an anti-PARP1 antibody. PARP1 was used as 
positive control (lane 1) and GST as negative control (lane 2). The lower panel shows a Coomassie 
stained PVDF membrane to quantify the protein levels of the H2B tails. MWM = Molecular Weight 
Marker 
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 In the full-length context of the H2B tail, substitutions of K27/28 and K30/34 to 
alanines had no impact on the PARP1 interaction. A loss of interaction was only observed 
when K27/28/30/34 as well as R29/31/33 were all substituted to alanines (K4R3A). Since 
substitutions of the four lysines alone (K4A) were not sufficient to abrogate the interaction, 
either the combination of the four lysines with the three arginines or the three arginines alone 
are responsible for the interaction of the H2B tail with PARP1. Surprisingly, these seven 
amino acids are not present in D1, although D1 was still interacting with PARP1. Since the 
observed interaction site with H2B-D1 is not observed with the mutated H2B-wt (K4R3A), 
the interaction with D1 might not be physiologically relevant.  
For the H2B tail, loss of (ADP-ribosyl)ation was only observed when K27/28/30/34 
as well as R29/31/33 were substituted to alanines (K4R3A, Table 2). This mutation was 
however not interacting any longer with PARP1 (Fig. 16), suggesting that the lack of (ADP-
ribosyl)ation was most probably due to a loss of interaction, thus not allowing to determine 
specific ADP-ribose acceptor sites of H2B with these experiments. 
 
 Table 2: Percentage of (ADP-ribosyl)ation and result of the interaction assay for H2B tail. 
 
2.8.3 R26 is important for the interaction of H3 with PARP1 
 Interaction assays with H3 tail deletions and mutations confirmed earlier results, that 
the interaction of H3 with PARP1 is abolished when using D3 (Fig.10C and 17). The slight 
interaction seen with D3 seemed to be background binding, since this interaction was not 
observed in other assays (e.g. Fig. 10C). 
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Figure 17: The upper panel is a western blot analysis using an anti-PARP1 antibody. PARP1 was used as 
positive control (lane 1) and GST as negative control (lane 2). The lower panel shows a Coomassie 
stained PVDF membrane to quantify the protein levels of the H3 tails. MWM = Molecular Weight 
Marker 
 
In the H3-D2 context, a loss of interaction was only observed when K23/27 as well 
as R26 were substituted to alanines (K23/27/R26A). Substitution of only K23/27 to alanines 
had no impact on the interaction, indicating that R26 is responsible for the interaction of the 
H3 tail with PARP1. 
For the H3 tail, loss of (ADP-ribosyl)ation was only observed when K23/27 as well 
as R26 were substituted to alanines (K23/27/R26A, Table 3). Since this mutant was also not 
interacting any longer with PARP1 (Fig. 17), the lack of (ADP-ribosyl)ation was likely due to 
a loss of interaction, thus not allowing to determine specific ADP-ribose acceptor sites of H3 
with these experiments. 
 
 Table 3: Percentage of (ADP-ribosyl)ation and result of the interaction assay for H3 tail. 
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2.8.4 K16/20 are possible acceptor sites as well as important for the 
interaction of H4 with PARP1 
 Interaction assays with H4 tail deletions and mutations confirmed earlier results, that 
the interaction of H4 with PARP1 is abolished when using D3 (Fig.10D and 18). 
 
  
Figure 18: The upper panel is a western blot analysis using an anti-PARP1 antibody. PARP1 was used as 
positive control (lane 1) and GST as negative control (lane 2). The lower panel shows a Coomassie 
stained PVDF membrane to quantify the protein levels of the H4 tails. MWM = Molecular Weight 
Marker 
 
In the H4-D2 context a loss of interaction was observed when K16/20 were 
substituted to alanines. Single lysine substitutions (K16A and K20A) did not cause a loss of 
interaction, indicating that both lysines are required for the interaction of the H4 tail with 
PARP1. 
By comparing these interaction results with the (ADP-ribosyl)ation results, possible 
acceptor sites were identified for H4 (Table 4). 
  For the H4 tail, single lysine substitutions (K16A, K20A) showed a 50% reduction 
of (ADP-ribosyl)ation, but were still interacting with PARP1, suggesting that these residues 
are possible ADP-ribose acceptor sites. Since substitution combination of both lysines K16/20 
to alanines revealed that (ADP-ribosyl)ation as well as interaction with PARP1 was not 
longer possible, these two lysines are possible acceptor sites and also important for the 
interaction with PARP1 (Fig. 18).  
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Table 4: Percentage of (ADP-ribosyl)ation and result of the interaction assay for H4 tail. Red labelled are the 
possible ADP-ribose acceptor sites. 
 
2.9  GST-tagged histone tails mainly interact with the BRCT 
domain of PARP1 
To determine which PARP1 domain is responsible for the interaction with the GST-
tagged histone tails, interaction assays with PARP1-fragments and the minimal histone tail 
deletions required for PARP1 interaction were performed. Five different myc-tagged PARP1-
fragments were used, comprising amino acid 1-214 which includes ZFI and II, amino acid 
215-371 which includes the ZBDIII, amino acid 372-525 which includes the BRCT domain, 
amino acid 525-656 which includes the WGR domain and a fragment including amino acid 
656-1014, which expresses the CAT domain. A PARP1-fragment interaction assay with 
30pmol of PARP1-fragments in absence of DNA was performed with all GST-tagged histone 
tails bound to glutathione-beads (as described in Materials and Methods, 4.2.5). Since some 
fragments were small, a 13% SDS-PAGE was used to separate bound PARP1-fragments by 
gel electrophoresis. After blotting the proteins onto a PVDF membrane, a western blot 
analysis using an anti-Myc antibody was performed. The presence of PARP1-fragments was 
visualized using enhanced chemiluminescence (Fig. 20). As input control, 30pmol of all 
PARP1-fragments were separated by 13% SDS-PAGE, blotted onto a PVDF membrane and 
analyzed by western blot using an anti-Myc antibody (Fig. 19).  
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Figure 19: The upper panel shows 100% Input of the PARP1-fragments detected by western blot using an anti-
Myc antibody. The lower panel shows a Coomassie stained PVDF membrane with the protein levels 
of the separated PARP1-fragments. MWM = Molecular Weight Marker 
 
 
H2A-D1: 
 
 
H2B-FL: 
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2.11 GST-PARP10(818-1025) (ADP-ribosyl)ate itself and histone 
tails in presence of eNAD+ 
Trans(ADP-ribosyl)ation analysis of GST-tagged histone tails was further more  
extended by using ethenoNAD+ as substrate for PARP1 or a protein fragment of PARP10 
comprising amino acids 818-1025, which includes the CAT domain. The usage of eNAD+ 
would allow first to perform (ADP-ribosyl)ation experiments without radioactive labelled 
NAD+ and the corresponding protection equipment, and second to detect eNAD+ 
incorporation by western blot. (ADP-ribosyl)ation assays with different eNAD+ 
concentrations and full-length GST-tagged H4 tail were performed. Samples were incubated 
with 10pmol of PARP1 for 5min at 30°C or with 10pmol of GST-PARP10(818-1025) for 
30min at 30°C in presence of different amounts of eNAD+ (as indicated in Fig. 22). The 
reaction was stopped and proteins separated by 12% SDS-PAGE. After gel electrophoresis, 
the proteins were blotted onto a PVDF membrane and analyzed by western blot using the IG4 
antibody, which detects the etheno mojety of eNAD+. The labelled proteins were visualized 
by enhanced chemiluminescence (Fig. 22). 
 
 
 
Figure 22: The upper panels are western blot analyses using the IG4 antibody to detect at which concentration of 
eNAD+, (ADP-ribosyl)ation is performed. The lower panels show Coomassie stained PVDF 
membranes to quantify protein levels of PARP and the histone tails. MWM = Molecular Weight 
Marker 
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2.12 Trans(ADP-ribosyl)ation of histone deletions and mutants by 
GST-PARP10(818-1025) 
To test whether GST-PARP10(818-1025) would (ADP-ribosyl)ate the different 
histone tail deletions and mutations at all and to identify possible ADP-ribose acceptor sites, 
GST-PARP10(818-1025)-mediated (ADP-ribosyl)ation assays in presence of 100nM 32P-
NAD+ and the available histone tails were performed. After 30min incubation at 30°C, 
reaction was stopped and the proteins separated by 12% SDS-PAGE. The gel was 
subsequently stained with Coomassie, vaccum dried and exposed to a Phosphor screen to 
quantify the incorporated radioactivity (see figures below). 
 
2.12.1 K13/15 are possible ADP-ribose acceptor sites of H2A modified by 
GST-PARP10(818-1025) 
 The minimal deletion mutant required for (ADP-ribosyl)ation by GST-
PARP10(818-1025) was H2A-D2, which correlated with the one found for PARP1 (Fig. 24). 
             
Figure 24: The upper panel shows the x-ray film to quantify the radioactivity coupled with (ADP-ribosyl)ation 
and the lower panel shows a Coomassie stained gel to quantify the protein levels of PARP and H2A 
tails. MWM = Molecular Weight Marker 
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In the H2A-D1 context a loss of (ADP-ribosyl)ation was observed when K13/R20 
and K15/R20 were substituted to alanines, but also when all three amino acids were 
substituted (K13/15/R20A). Since substitution of R20 alone did not reduce (ADP-
ribosyl)ation in the H2A-D1 context, the substitution of K13 and K15 is most probably 
responsible for the loss of (ADP-ribosyl)ation, thus pointing at K13 and K15 as acceptor sites. 
However, since a reduction of about 50% of (ADP-ribosyl)ation was observed when H2A-wt 
was deleted to D1, additional modification sites for PARP10 are suggested to be located 
between amino acids 26-34. 
 
2.12.2 K27/28/30/34/R29/31/33 are possible ADP-ribose acceptor sites of 
H2B modified by GST-PARP10(818-1025) 
In the full-length context of the H2B tail a loss of (ADP-ribosyl)ation by GST-
PARP10(818-1025) was observed when K27/28/30/34 as well as R29/31/33 were substituted 
to alanines (K4R3A, Fig. 25). 
                   
Figure 25: The upper panel shows the Phosphor Image of the gel to quantify the radioactivity coupled with 
(ADP-ribosyl)ation and the lower panel shows a Coomassie stained gel to quantify the protein levels 
of PARP and H2B tails. MWM = Molecular Weight Marker 
 
H2B tails with substitutions of the four lysines (K4A) or the three arginines (R3A) 
alone were still (ADP-ribosyl)ated. Only when all seven substitutions were combined, (ADP-
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ribosyl)ation was completely lost, suggesting that all seven amino acids together are 
important for (ADP-ribosyl)ation. This (ADP-ribosyl)ation pattern correlated with the one 
observed for PARP1. The only difference was the slight modification of GST (negative 
control), which was already seen in earlier experiments (Fig. 6 and 23). Together, these 
results suggest that K27/28/30/34 as well as R29/31/33 of H2B are the most important 
residues for trans(ADP-ribosyl)ation by the CAT domain of PARP10. 
 
2.12.3 H3 tail is not modified by GST-PARP10(818-1025)  
All tested H3 tail deletions and mutations showed the same low (ADP-ribosyl)ation 
levels, which correlated with the signal observed for GST (negative control, Fig. 26), 
indicating that GST-PARP10(818-1025) is not able to trans(ADP-ribosyl)ate the H3 tail. 
 
                    
Figure 26: The upper panel shows the Phosphor Image of the gel to quantify the radioactivity coupled with 
(ADP-ribosyl)ation and the lower panel shows a Coomassie stained gel to quantify the protein levels 
of PARP and H3 tails. MWM = Molecular Weight Marker 
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2.12.4 K16/20 and R17/19 are possible ADP-ribose acceptor sites of H4 
modified by GST-PARP10(818-1025) 
Since H4-D2 was the minimal modified deletion mutant by PARP1, it was 
speculated that this might also be the one modified by GST-PARP10(818-1025). Indeed, H4-
D2 was also (ADP-ribosyl)ated by GST-PARP10(818-1025) (Fig. 27). 
                   
Figure 27: The upper panel shows the Phosphor Image of the gel to quantify the radioactivity coupled with 
(ADP-ribosyl)ation and the lower panel shows a Coomassie stained gel to quantify the protein levels 
of PARP and H4 tails. MWM = Molecular Weight Marker 
 
In the H4-D2 context a loss of (ADP-ribosyl)ation was observed when K16/20 or 
R17/19 or all four amino acids together (K2R2A) were substituted to alanines. The H4 tail 
with single lysine substitutions (K16A or K20A) was still (ADP-ribosyl)ated, suggesting that 
multiple lysines are modified by PARP10. This (ADP-ribosyl)ation pattern correlated with the 
one observed for PARP1. Taken together, K16/20 and R17/19 seemed to be important 
residues for trans(ADP-ribosyl)ation by the CAT domain of PARP10. 
 
All together these experiments provide evidence that distinct lysine and arginine 
residues are important for (ADP-ribosyl)ation by GST-PARP10(818-1025). Whether this is 
due to a lack of interaction has to be further analyzed (including single amino acid mutants), 
but is less likely to be the case, since mass spectrometric analyses confirmed these sites for 
H4 (see Discussion). 
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3  Discussion 
The aim of this thesis was to investigate whether histone tails are (ADP-ribosyl)ated by 
PARP1, PARP2 and PARP10 and furthermore to identify potential ADP-ribose acceptor sites 
of the core histone tails. Core histone tails were cloned into pGEX-2T vectors and expressed 
as GST-fusion proteins to perform PARP-mediated (ADP-ribosyl)ation and interaction 
assays. Trans(ADP-ribosyl)ation of histone tails was only observed for PARP1 and GST-
PARP10(818-1025), but not for PARP2, although all three PARPs were able to perform 
auto(ADP-ribosyl)ation. High NaCl concentrations inhibited the enzymatic activity of 
PARP1, by inhibiting its interaction with histone tails, suggesting that the interaction is of an 
electrostatic nature. The minimal deletion mutants of all GST-tagged histone tails required for 
the interaction with PARP1 were identified and correlated with the ones required for 
trans(ADP-ribosyl)ation, except for H2B, where a second interaction site was identified, 
which seemed to be unphysiological. Furthermore, substitutions of lysines and arginines to 
alanines in the full-length as well as deletion mutant, which could still interact, were used to 
identify potential ADP-ribose acceptor sites of the histone tails. These experiments revealed 
that distinct lysines and arginines are responsible for the modification. Addition of DNA had 
no impact on the interaction of PARP1 with GST-tagged histone tails and the BRCT as well 
as Ac domain of PARP1 were identified as the responsible domains for interaction with 
histone tails. The same experiments were repeated with GST-PARP10(818-1025). (ADP-
ribosyl)ation assays revealed that distinct lysines and arginines are also the most important 
residues for modification by GST- PARP10(818-1025). 
 
(ADP-ribosyl)ation of histone tails 
This is the first time that (ADP-ribosyl)ation of histone tails has been reported, since 
only (ADP-ribosyl)ation of full-length histones has been described so far. Some studies 
reported that H1 is the most modified histone followed by H2B, H2A, H4 and H3. This 
differs from our result, in which the H2A tail was modified stronger than the other tails. The 
difference might be explained by the fact that full-length histones have additional 
modification sites, besides the one identified in the tail. 
PARP2 was not able no trans(ADP-ribosyl)ate histone tails, which is probably because 
of structural differences in the CAT domain. This is strengthened by the fact that a different 
substrate specifity for PARP1 and 2 was already described (140). GST-PARP10(818-1025) 
trans(ADP-ribosyl)ated the histone tails with the same specifity as observed for PARP1, 
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despite the fact that the glutamate in the catalytic site is missing in this protein, providing 
evidence that the glutamate itself is not important for substrate specifity. 
 
Lysines are ADP-ribose acceptor sites 
Together our studies identified lysines as ADP-ribose acceptor amino acids of the 
histone tails and not the glutamic acid residues as suggested by Ogata et al. (97, 100). In the 
1970s several laboratories identified glutamic acid residues in histone H1 and H2B to be 
modified when they incubated chromatin from rat liver with radioactive NAD+ (97, 100-102). 
At that time, no other PARP family member except PARP1 was identified yet, and no 
knockdown-system was available (99). The modification of glutamic acid residues as acceptor 
sites was never verified using purified enzymes (e.g. PARP1) nor confirmed by mutagenesis 
or mass spectrometry (141). Thus, it is possible that other PARP family members or even 
unrelated NAD+ consuming enzymes were responsible for the modification at the identified 
glutamates and that PARP1 modifies lysine residues (99). For some histone tails, defined 
lysines could be identified as acceptor site, by (ADP-ribosyl)ation assays as well as mass 
spectrometric analyses. While for other histone tails additional single mutations or mass 
spectrometric analyses would be required to determine the exact acceptor site modified by 
PARP1 or PARP10. For this kind of analysis, (ADP-ribosyl)ated peptides were acetone 
precipitated and analyzed by liquid-chromatography coupled mass spectrometry. The 
modified peptides were analyzed by ETD (electron transfer dissociation) resulting in an 
almost complete fragmentation of the multiple charged histone peptides (99). Fragmentation 
of the mono(ADP-ribosyl)ated H3 peptide revealed specific (ADP-ribosyl)ation of K27 and 
K37 by PARP1. For the H4 peptide, mass spectrometric analysis identified K16 to be (ADP-
ribosyl)ated by PARP1. These sites represent two known sites of frequent histone 
modification (H3K27 and H4K16), as described in 1.2.3 and below, as well as a novel 
modification site (H3K37) (99). 
Since the attachment of an ADP-ribose reverses the positive charge of an amino acid 
into a negative charge, the functional consequence of lysine (ADP-ribosyl)ation can be 
assumed to be even more drastic than other posttranslational modifications. Therefore, the 
possible effects on chromatin architecture, histone dynamics, histone degradation and histone 
variant incorporation may be dramatic (99). 
Furthermore, certain posttranslated ADP-ribose acceptor sites are also important for the 
interaction with PARP1 (e.g. R20 of H2A or K16 and K20 of H4), indicating that the 
modified lysine is contacting in the active site a negative amino acid, which would stabilize 
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the interaction but also allow Schiffbase formation with the ADP-ribose. To provide evidence 
that the observed (ADP-ribosyl)ation of lysine residues is not a result of non-enzymatic 
Schiffbase formation, but rather specifically mediated by PARP1, mass spectrometric 
analyses were performed using peptides incubated with NAD+ alone or in presence of ADP-
ribose and PARP1. These analyses provided evidence that the modification of lysines is 
indeed specifically catalyzed by PARP1 (99). 
 
Cross-talk with other modifications 
Since we identified K16 of the H4 tail as ADP-ribose acceptor site, which was already 
reported to be an acceptor site for acetylation, cross-talk between these two modifications can 
be expected. Acetylation of H4K16 occurs frequently in eukaryotic cells and has been 
correlated with chromatin decompaction (4, 99). If H4K16 is indeed an acceptor site for 
PARP1-mediated (ADP-ribosyl)ation, acetylation at this site should impair (ADP-
ribosyl)ation. Our laboratory tested this hypothesis with H4 chemically acetylated at K16 in 
mass spectrometry and in (ADP-ribosyl)ation assays with radioactive NAD+. Both assays 
revealed that PARP1 was not any longer able to induce (ADP-ribosyl)ation of the acetylated 
peptide. These results support the conclusion that H4K16 is indeed modified by PARP1 and 
that acetylation of K16 inhibits (ADP-ribosyl)ation of the H4 peptide. To test in vivo whether 
PARP1 would interfere with this histone modification, PARP1 was transiently knocked down 
in asynchronous HeLa cells and extracted histones were assessed for cellular H4K16ac levels. 
Interestingly the levels of H4K16ac were increased in PARP1-depleted extracts, suggesting 
that PARP1-mediated (ADP-ribosyl)ation interferes with H4K16 acetylation also in vivo (99). 
Possibly, (ADP-ribosyl)ation of histone H3 and H4 also interferes with other 
posttranslational modifications on the same lysines. For example, H3K27 is methylated by 
EZH2 (enhancer of zeste homolog 2), which is in the polycomb group complex that is 
involved in maintenance of the inactive X-chromosome (99, 142). Interestingly, PARP1 was 
demonstrated to participate in the maintenance of X-chromosome silencing as well (99, 143). 
On the other hand, the stretch between K16 and K20 of the H4 tail, was shown to be required 
for chromatin fiber formation and for interaction with various non-histone modulators, such 
DV $OF ZKLFK QHHGV WKLV VWUHWFK IRU LW¶V DFWLYLW\ (99, 144). Interestingly, recent reports 
provide evidence that the ATPase activity of Alc1 is highly stimulated by binding to 
poly(ADP-ribosyl)ated PARP1 (99, 144, 145). Whether (ADP-ribosyl)ated H4 would activate 
Alc1, remains to be investigated. 
 

Discussion  
 
 
55
PARP1 plays a crucial role in genotoxic stress signalling by poly(ADP-ribosyl)ing core 
histones. Cancer cells rely very much on the activity of PARP1, since inhibition of PARP1 
induces cell death in cells deficient for homologous recombination regulated by BRCA1 and 
BRCA2 (147). Extending this analysis of acceptor sites for histones but also for other nuclear 
proteins in cancer cells, with the aim to identify more acceptor sites, would possibly help to 
further elucidate the beneficial effect of PARP inhibition in cancer therapy. 
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4 Material and Methods 
4.1 Molecular Biology Methods 
4.1.1 Overlapping PCR 
Overlapping PCR was used in this thesis to introduce a site specific mutation in a 
DNA strand (e.g. lysines and arginines were substituted to alanines). For this purpose 4 
different primers were designed. In this thesis, a BstBI-primer ¶AATGTTCGAAGATC 
GTTTATGTC3¶) and a PstI-primer ¶ATTGCTGCAGGCATC GTGGTGTCAC3¶) on the 
plasmid were used for flanking the whole amplified region, together with a reverse as well as 
a forward primer, which encoded the desired mutation (sequence of alanine). In a first PCR, 
two PCR products were amplified using one flanking primer and one mutation primer. The 
ILUVWSURGXFW¶WRWKHPXWDWLRQVLWHZDVSURGXFHGE\%VW%,-primer and the reverse primer, 
and the VHFRQGSURGXFW¶WRWKHPXWDWLRQVLWHZDVSURGXFHGE\WKHIRUZDUGSULPHUDQG3VW,-
primer. The PCR-Mix contained ȝ0 of each primer, ȝ0 of G173¶V ȝORI[3KXVLRQ
buffer HF, 100ng of DNA-template and 1Unit of Phusion-polymerase (Finnzyme) and was 
adjusted with H22 WR D VDPSOH YROXPH RI ȝO The first PCR began with 5min at 95°C, 
followed by 25 cycles of 30sec at 95°C, 30sec at 55°C and 30sec at 72°C, and finished with 
7min at 72°C. The second product was slightly longer and therefore the incubation time was 
extended to 1min (at 72°C) instead of 30sec. 
$IWHU WKH ILUVW 3&5 ȝO RI HDFK 3&5 SURGXFW ZDV ORDGHG RQ D  $JDURVH JHO
(Agarose from Promega Corporation) to control the amplified products. The Agarose gel was 
run with 1x TAE buffer (40mM Tris acetate, 1mM EDTA, 0.1% Acetic acid) for 20min at 
80V. These PCR products were further used in a second PCR round, which was an 
overlapping PCR using both PCR products from the first round and only the flanking primers, 
to generate one combined PCR product. Due to the complementarity of the primers at the 
mutation site, overlapping PCR elongation occurs, combining the first and the second product 
spanning the region from the BstBI to the PstI restriction site. )RUWKLVRYHUODSSLQJ3&5ȝO
RIWKHILUVW3&5SURGXFWDQGȝORIWKH second PCR product was used together with ȝ0of 
BstBI-SULPHU ȝ0 of PstI-primer, ȝ0 RI G173¶V ȝO RI [3KXVLRQ buffer HF and 1 
Unit of the Phusion-polymerase and was adjusted with H22WRDVDPSOHYROXPHRIȝO The 
thermo cycles for this amplification were the same as above for the second product. After 
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4.2.2 Purification of GST-tagged histone tail proteins 
To purify the GST-tagged histone tails, 1ml of the crude protein extract was diluted 
with 2.5ml of EBC-buffer (120mM NaCl, 50mM Tris-HCl (pH 8.0), 0.5% (v/v) NP-40, 5mM 
DTT, 1mM PMSF) in a 15ml falcon tube. 1H[W ȝO VOXUU\ RI JOXWDWKLRQH-beads 
(Glutathione-SepharoseTM4B, in 20% Ethanol: GE Healthcare) were equilibrated with 1ml of 
EBC-buffer $IWHU FHQWULIXJDWLRQ IRU PLQ DW ¶USP ¶UFI Whe supernatant was 
discarded and the diluted crude protein extract containing the GST-tagged histone tail proteins 
was incubated with the beads for 1h at 4°C on rolls. The falcons were subsequently 
FHQWULIXJHGDW¶USP ¶UFI IRUPLQ The supernatant was discarded and the beads 
were washed 3 times with 5ml of EBC-buffer. Between the washing steps the falcons were 
FHQWULIXJHGIRUPLQDW¶USP¶UFI8VXDOO\FKDUJHGEHDGVZHUHDOVRHTXLOLEUDWHG
once with 7ml of (ADP-ribosyl)ation-buffer (50mM Tris-HCl (pH 8.0), 4mM MgCl2ȝJPO
SHSVWDWLQȝJPOEHVWDWLQȝJPOOHXSHSWLQȝ0'77. After discarding the supernatant, 
300ȝO RI $'3-ribosyl)ation-buffer with 10mM glutathione (L-Glutathione reduced, 
minimum 99%, Sigma-Aldrich) was added to the beads to elute the GST-tagged histone tail 
proteins from the beads. It was incubated overnight at 4°C or for 45min at room temperature 
on rolls. )LQDOO\ WKH VDPSOHV ZHUH FHQWULIXJHG IRU PLQ DW ¶USP ¶UFI DQG WKH
supernatant with the purified protein was stored in liquid nitrogen. 
 
4.2.3 Bradford Protein Assay 
To measure the protein concentrations of the eluted proteins, Bradford assay was 
used. This assay uses BIO-RAD solution (BIO-RAD Protein Assay, Bio-Rad Laboratories 
GmbH), which stains proteins blue. Color change can be detected in a Spectrometer at 
595nm. For this assay the 5x concentrated BIO-RAD solution was diluted with ddH2O to a 1x 
concentrated solution. To 1ml of 1x concentrated BIO-RAD solution, 5-20ȝl of protein were 
added. As standard concentrations, 20ȝl of 4 known BSA (FLUKA Analytical) concentrations 
were used, 0.2mg/ml, 0.36mg/ml, 0.54mg/ml and 0.72mg/ml respectively. The values at 
595nm of these protein concentrations, served as a standard curve, with which an unknown 
protein concentration could be determined. 
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containing (ADP-ribosyl)ation-buffer (50mM Tris-HCl (pH 8.0), 4mM MgCl2 ȝJPO
SHSVWDWLQ ȝJPO EHVWDWLQ ȝJPO OHXSHSWLQ ȝ0 '77. Between the washing steps the 
VDPSOHVZHUH FHQWULIXJHG IRUPLQDW ¶USP ¶UFI DW C. Interaction with PARP1 
was performed by addition of 10pmol of PARP1 with or without 5pmol of EcoRI-linker DNA 
to the beads while the volume was adjusted with 0-50mM NaCl-containing (ADP-
ribosyl)ation-buffer to 300ȝO. The samples were incubated for 2hours on the rotating wheel at 
4°C.  To remove the unbound PARP1, the samples were washed 3 times with 1ml of 0-50mM 
NaCl-containing (ADP-ribosyl)ation-buffer. The supernatant was discarded and 20ȝO RI [
SDS-sample-buffer was added to the beads. After boiling for 5min at 95°C, the beads were 
loaded on a SDS-PAGE, followed by western blot (see 4.2.8) to analyze if PARP1 had 
interacted with the different GST-tagged target proteins. 
 
4.2.6 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
The sodium dodecyl sulfate polyacrylamide gel (SDS-PAGE), is used to separate 
proteins based on their molecular weight. First, one glass plate (10 x 8.5cm) and one teflon 
plate were cleaned with Ethanol (70%) and two spacers (10 x 0.15cm) placed in between 
them. The assembled plates were put into a gel preparation unit and was filled with about 8ml 
of separation gel solution (12% SDS-PAGE: 3.6ml ddH2O, 2.0ml Solution B (1.5M Tris-HCl 
(pH 8.8), 0.4% (w/v) Na-dodecylsulfate), 2.4ml Acrylamide (Acrylamide-Bis solution 
(37.5:1), 40% (w/v), SERVA Electrophoresis GmbH ȝO $36  ȝO 7(0('. As 
soon as the chamber was filled, 1ml of H2O was added to generate a plain surface of the gel. 
After 20min the gel was normally polymerized, allowing the water to be replaced by 3ml of 
stacking gel solution (3ml of 4% (v/v) stacking solution (65ml ddH2O, 25ml Solution C (0.5M 
Tris-HCl (pH 6.8), 0.4% (w/v) Na-dodecylsulfate and a tip of Bromphenol blue), 10ml of 
 $FU\ODPLGH ȝO $36  ȝO 7(0('. A comb containing 10 or 15 flaps was 
inserted into the stacking gel solution before polymerization, to generate the sample pockets. 
Usually, the SDS-gels were poured freshly, that means about 30min before usage. Sometimes, 
the gel was poured earlier and stored at 4°C overnight. The polymerized gel was placed into a 
running unit, which was filled with 1x SDS running buffer (25mM Tris base, 200mM 
Glycine, 0.1% (w/v) Na-dodecylsulfate). The comb was removed and the sample pockets 
rinsed with the 1x SDS running buffer. Into the first sample pocket 4ȝORISee Blue ® Plus 2 
Prestained Standard (1x from invitrogen) was loaded, which is a marker of distinct molecular 
weights. Into the other pockets the different samples were loaded and run for 20min at 90V to 
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allow proteins to stack and reach the beginning of the separation gel. After that the voltage 
was raised to 130V for 1 hour. Finally slides were removed from the gel, which was either 
stained or blotted (as described in 4.2.8). For staining, the gel was soaked in Coomassie 
(0.25% (w/v) Coomassieblue R250, 40% (v/v) Methanol, 10% (v/v) Acetic acid) for 10min, 
destained with Fast Destain (12% (v/v) Methanol, 10% (v/v) Acetic acid) and then used for 
Quantification by Phosphor Imaging (as described in 4.2.7).  
 
4.2.7 Quantification by Phosphor Imaging 
Phosphor Imaging was used to quantify the amount of radioactivity. The phosphor 
screens retain emitted energy from beta particles, X-rays and gamma rays. The retained 
energy is emitted as light from the phosphor screen upon laserinduced stimulation, in 
proportion to the amount of stored radioactivity. The emitted light is collected and converted 
to an electrical signal by a photomultiplier. The electrical signal is digitized to permit image 
display and analysis. Phosphor Imaging was specifically used to measure the amount of 
radioactivity, which was incorporated by (ADP-ribosyl)ation of the GST-tagged histone tails. 
The gel was exposed to a Phosphor screen (Molecular Dynamics) overnight or at least for 
2hours. Afterwards the screen was scanned by a Typhoon 9400 (Amersham Biosciences) and 
the resulting digital file was edited with the program ImageQuant 5.0 (Molecular Dynamics). 
 
4.2.8 Western Blot Analysis 
Western blot analysis is used to specifically detect proteins or posttranslational 
modifications such as poly(ADP-ribos\ODWLRQ )RU D ZHVWHUQ EORW D ³VDQGZLFK´ ZDV
assembled in a bath of 1x Transfer buffer (20% (v/v) Methanol, 70% ddH2O, 10% (v/v) 10x 
Transfer buffer (25mmol/l Tris-base, 192mmol/l Glycine, dissolved in ddH2O)) as follows: 
one wetted sponge, two pre-wetted Wattman-papers, one PVDF membrane (Millipore, Pore 
size: 0.45um), which was first activated by 100% Methanol, the polyacrylamide gel with the 
separated proteins, followed by two pre-wetted Wattman-papers and one wetted sponge. The 
plastic frame with the sandwich was put into a western blot chamber, which was filled with 
1x Transfer buffer and an ice bloc. The blotting was done for 90min at 100V at 4°C. To 
confirm that proteins were blotted successfully from the gel onto the PVDF membrane, the 
membrane was stained shortly with 1x Ponceau and destained with deionized water and TBS-
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Abstract 
The chromatin-associated enzyme PARP1 has previously been suggested to 
ADP-ribosylate histones, but the specific ADP-ribose acceptor sites have 
remained enigmatic. Here, we show that PARP1 covalently ADP-ribosylates the 
amino-terminal histone tails of all core histones. Using biochemical tools and 
novel ETD mass spectrometric protocols, we identify for the first time K13 of 
H2A, K30 of H2B, K27 and K37 of H3, as well as K16 of H4 as ADP-ribose 
acceptor sites. Multiple explicit water molecular dynamics simulations of the H4 
tail peptide into the catalytic cleft of PARP1 indicate that two stable 
intermolecular salt bridges hold the peptide in an orientation that allows K16 
ADP-ribosylation. Consistent with a functional cross-talk between ADP-
ribosylation and other histone tail modifications, acetylation of H4K16 inhibits 
ADP-ribosylation by PARP1. Taken together, our computational and 
experimental results provide strong evidence that PARP1 modifies important 
regulatory lysines of the core histone tails. 
 
Keywords: PARP-1, H3K27, H4K16, chromatin, ADP-ribosylation 
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Introduction 
Histone proteins form the nucleosome, which is the fundamental repeating unit of 
chromatin (1,2). Each nucleosome contains two heterodimers of the core histones 
H2A and H2B, one tetramer of the core histones H3 and H4, and 146 base pairs of 
DNA (3). Dynamic chromatin structures are governed in part by post-translational 
modifications of the histones, modification of nucleotides, remodeling of 
nucleosomes, and by non-coding RNAs or non-histone DNA-binding proteins (4). 
The amino-terminal tails of the core histone proteins protrude from the nucleosome. 
They appear to be unstructured and are believed to participate in the formation of 
higher order chromatin structures by mediating internucleosomal interactions and to 
contact the linker DNA (3,5). A large number of residues within the histones are 
modified by post-translational modifications including acetylation, phosphorylation, 
methylation, ubiquitination and ADP-ribosylation, which occur in distinct patterns 
(6). Recent work has provided compelling evidence that these modifications influence 
the functional properties of chromatin.  
 Histones have long been known as substrates for ADP-ribosylation in vivo (7). 
Histones isolated from rat liver nuclei and HeLa cells incubated with radioactive 
NAD+ revealed that the linker histone H1 and all core histones, H2A, H2B, H3 and 
H4, are ADP-ribosylated, although to a variable extent (8-12). An unresolved issue 
regarding the mechanism of ADP-ribosylation of histones is whether this modification 
primarily occurs at the globular histone domains or at their unstructured amino-
terminals tails. Moreover, unconfirmed ADP-ribose acceptor amino acids have 
previously only been proposed for H1 and H2B, but not for H2A, H3 and H4 (11,13-
15).  
 Poly(ADP-ribose) polymerase 1 (ARTD1/PARP1) is a nuclear chromatin-
associated multifunctional enzyme that is present in most eukaryotes apart from yeast 
(16). The enzyme is responsible for most of the cellular poly(ADP-ribose) formation. 
Targets of PARP1’s enzymatic activity include a variety of nuclear proteins, most 
prominently PARP1 itself, as well as histone proteins (17). Among the six PARP 
family members, PARP2 has the highest similarity with PARP1 (43% sequence 
identity in the catalytic domain) (18). PARP2 displays similar automodification 
properties as PARP1 and may account for the residual poly(ADP-ribose) synthesis 
observed in PARP1 knockout mice. 
 Recently, we showed that individual lysine residues of PARP1 and PARP2 
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function as acceptor sites for auto-ADP-ribosylation and not, as previously assumed, 
glutamic acid residues (19,20). Here, we report PARP1-mediated ADP-ribosylation of 
the core histone proteins. We found that PARP1, but not PARP2, ADP-ribosylates 
core histone proteins at their amino-terminal tails. Mass spectrometry of ADP-
ribosylated histone peptides revealed that the lysine residues K13 of H2A, K30 of 
H2B, K27 and K37 of H3, as well as K16 of H4, are specifically ADP-ribosylated by 
PARP1. Acetylation of H4K16 or mutation of this residue to an alanine abrogated 
ADP-ribosylation. Molecular dynamics (MD) simulations of tetra- and octapeptide 
segments of the amino terminal tail of H4 indicated that two positively charged side 
chains at position n and n+1 in the histone sequence, which point in opposite 
directions, are engaged in favorable electrostatic interactions with two acidic PARP1 
residues at the positions 988 and 756, buried in the catalytic cleft and on a loop at the 
entrance of the cleft, respectively. Taken together, our results reveal that PARP1 
specifically modifies lysine residues of the core histone tails, which are known to 
control chromatin structure and function. 
 5 
Materials and Methods  
Chemicals and antibodies 
32P-NAD+ was purchased from PerkinElmer. NAD+ was obtained from Sigma-
Aldrich. Anti-PAR (LP-96-10) antibody was from Becton Dickinson. Anti-PARP1 
antibody was generated in this laboratory. PARP-inhibitor DAM-TIQ-A was obtained 
from Alexis Biochemicals, PJ34 was purchased from Enzo Life Science, 3-amino-
benzamide (3AB) was from Sigma-Aldrich. Peptides were from PiProteomics. 
ProbondTM nickel beads were from Invitrogen. Glutathione-Sepharose 4B affinity 
beads were from GE-healthcare. 
 
Plasmids 
The baculovirus expression vectors pQE-TriSystem (Qiagen) and BacPak8 (Clontech) 
were used for the expression of recombinant proteins in Sf21 cells as described 
(21,22). pGEX-2T vectors (GE healthcare) were used for the cloning and expression 
of GST-fusion proteins. Full-length and truncated histone proteins were expressed in 
pET3a or pET3d vectors, as described (3). Sequencing of plasmids was performed by 
Microsynth (Balgach, CH). 
 
Cloning, expression and purification of recombinant proteins 
Human PARP1 and PARP2 were cloned, expressed and purified as described (19). 
Full length histone proteins were generated as described (3). GST-histone tail fusion 
proteins were generated by PCR and cloned into pGEX-2T vector. Truncated and 
mutated versions of GST-fusion proteins were generated by cloning with BstBI and 
EcoRI restriction sites. Primers for PCR and direct cloning were obtained from 
Sigma-Aldrich and Microsynth. pGEX-2T plasmids were transformed into 
BL21(DE3) bacteria and expression was induced by addition of 1 mM IPTG into LB-
medium for 3 hours at 30°C. After centrifugation and resuspension in EBC-buffer 
(120 mM NaCl, 50 mM Tris-pH 8.0, 0.5% NP-40, 5 mM DTT, 1 mM PMSF), 
bacteria were lysed by the addition of lysozyme (0.5 mg/ml) and the DNA was 
sheared by a French Press. After centrifugation the supernatant was taken and the 
proteins were bound to GST-beads and washed extensively with EBC-buffer. The 
GST-beads with the bound GST-fusion proteins were equilibrated with ADP-
ribosylation buffer (50 mM Tris-HCl, pH 8.0, 4 mM MgCl2, 250 µM DTT, 20 mM 
 6 
NaCl, 1 µg/ml protease inhibitors pepstatin, leupeptin and bestatin) and after 
extensive washing eluted from the GST-beads with 10 mM reduced glutathione in 
ADP-ribosylation buffer.  
 
ADP-ribosylation assays 
32P-NAD+ ADP-ribosylation was performed as previously described (19). Briefly, 20 
µg histone mix from calf thymus (Roche) were incubated with 10 pmol PARP1 or 
PARP2 in a 25 µl reaction, containing 5 pmol annealed EcoRI-linker DNA and 100 
nM 32P-NAD+ in ADP-ribosylation buffer (50 mM Tris-HCl, pH 8.0, 4 mM MgCl2, 
250 µM DTT, 20 mM NaCl, 1 µg/ml protease inhibitors pepstatin, leupeptin and 
bestatin) for 10 min at 30°C. ADP-ribosylation of full-length or truncated single 
histones was performed with 3 µg full-length or truncated histone proteins and 10 
pmol PARP1 in a 25 µl reaction. ADP-ribosylation of GST-histone tail fusion 
proteins was performed with 1.5 µg purified fusion protein, together with 10 pmol of 
PARP1. 5 pmol EcoRI-linker DNA was always included into the reaction to activate 
PARP1 enzymatic activity. ADP-ribosylation assays with full-length or truncated 
histones were resolved by a 10-20% acrylamide gradient SDS-gel of 15 cm length 
(Amersham). Assays with GST-fusion proteins were resolved on standard 12% 
acrylamide mini-gels (Hoefer). Radiolabeled proteins were visualized by exposure to 
X-ray films or by quantification through the phospho-imager system (Molecular 
Dynamics).  
For mass spectrometry, 22 nmol biotinylated H2A (aa 3-23), H2B (aa 18-37), 
H3 (aa 23-42), H4 (aa 1-22) or H4K16ac (aa 1-22) peptides were incubated with 10 
pmol PARP1, 5 pmol annealed EcoRI-linker and 100 µM or 500 µM NAD+ for 15 
min at 30°C in ADP-ribosylation buffer without protease inhibitors. The reaction was 
stopped by the addition of 3AB to a final concentration of 20 mM and subsequently 1 
µg GST-ARH3 was added to the reaction and further incubated for 1 hour at 30°C. 
The samples were acetone precipitated and the pellet was dissolved in distilled water.  
 
GST-pulldown 
Glutathione-sepharose affinity beads were incubated with a bacterial extract of the 
GST-fusion protein expression in EBC-buffer. After extensive washing, the GST-
beads were equilibrated with ADP-ribosylation buffer containing 50 mM NaCl. After 
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washing, 10 pmol purified PARP1 was added to the beads in a total volume of 300 µl 
ADP-ribosylation buffer. The protein mixture was incubated for 2 hour at 4°C on rolls 
to allow for protein-protein interaction. The samples were washed again with ADP-
ribosylation buffer and resolved on standard SDS-PAGE and subsequent western 
blotting with anti-PARP1 antibody. 
 
Microvolume C-18 reversed phase purification 
22 nmol H4-peptide (aa 1-22) was incubated with 10 pmol PARP1, 5 pmol EcoRI-
linker DNA and 100 nM 32P-NAD+ in 25 µl ADP-ribosylation buffer for 15 min at 
30°C. The reaction was stopped by the addition of 3AB to a final concentration of 20 
mM. The C18 reversed phase ZIP-tip (Millipore) was pre-wetted with 100% 
Methanol and equilibrated with 3% (v/v) acetonitrile. The peptides were bound onto 
the column and subsequently washed extensively with 3% (v/v) acetonitrile. Bound 
peptides were eluted by 60% (v/v) acetonitrile directly into scintillation liquid. In the 
control reaction, peptides were added after the addition of 3AB to the reaction. 
Scintillation counts were measured and normalized to the control reaction and the 
relative increase in scintillation counts was calculated (cpm).  
 
Mass spectrometry 
ETD experiments were performed on a hybrid LTQ Orbitrap XL ETD mass 
spectrometer (Thermo Scientific, Bremen, Germany) coupled to an Eksigent nano LC 
system (Eksigent Technologies) and analyzed by reversed-phase liquid 
chromatography nanospray tandem mass spectrometry (LC-MS/MS). 
Peptides were resuspended in 3% ACN and 0.2% formic acid, loaded from a 
cooled (10°C) Spark Holland autosampler (Emmen, Holland) and separated using an 
ACN/water solvent system containing 0.2% formic acid with a flow rate of 200 
nL/min. Separation of the peptides was performed on a 10 cm long fused silica 
column (75 !m i.d.; BGB Analytik) in-house packed with 3 µm, 200 Å pore size C18 
resin (Michrom BioResources, CA). Elution was achieved using a gradient of 3"48% 
ACN in 35 min, 48"80% ACN in 4 min and 80% ACN for 7 min. 
One scan cycle was comprised of a survey full scan MS spectra from m/z 300 
to m/z 2000 were acquired in the FT-Orbitrap with a resolution of R= 60‘000 at m/z 
400, followed by up to four sequential data- dependent ETD MS/MS scans with 
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detection of the ETD fragment ions in the linear ion trap. AGC target values were 5e5 
for full FTMS scans, 1e4 for ion trap MSn scans. Anion target value was 1e6 and 
supplementary activation was employed to enhance the fragmentation efficiency for 
doubly-charged precursors and charge state dependent ETD time was enabled. Data 
dependent decision tree was used in order to control ETD dissociation based on 
charge state and m/z. The ETD reaction time was set at 100 ms and the isolation 
width was m/z 2. For all experiments dynamic exclusion was used with one repeat 
count, 30 s repeat duration, and 10 s exclusion duration. 
The instrument was calibrated externally according to the manufacturer's 
instructions. The samples were acquired using internal lock mass calibration on m/z 
429.088735 and 445.120025. Spectra generated by ETD were processed using Mascot 
Distiller 2.2 (Matrix Science) and data was searched against a SwissProt human 
database using Mascot 2.2.0 to find best matching sequences. Detailed spectra 
analysis was done by manual evaluation. 
 
Molecular dynamics 
It is computationally prohibitive to dock the full-length histone tails to PARP1. 
Therefore, only the relevant tetra- and octapeptide segments of the histone tails 
(abbreviated H-peptides hereafter) were taken into account in the present study. A 
two-step procedure was used to investigate the binding of the H-peptides to PARP1 
(PDB ID: 1A26). Preliminary binding modes of the flexible H-peptides into the rigid 
structure of the catalytic domain of PARP1 were obtained by an in-house developed 
docking program, which uses a combination of simulated annealing and genetic 
algorithm optimization of position, orientation, and rotatable bonds of the ligand 
(Zhao et al., unpublished). Explicit solvent molecular dynamics (MD) simulations of 
the H-peptide/PARP1 complexes were then used to investigate the structural stability 
of the poses obtained by docking. In both docking and MD simulations, the N-
terminus and C-terminus of the H-peptides were capped by neutral groups (acetyl and 
N-methlyamide, respectively) to take into account the fact that they belong to a longer 
polypeptide chain. To reproduce physiological pH conditions, the side chains of 
aspartates and glutamates were negatively charged, those of lysines and arginines 
were positively charged, while all other residues were considered neutral. The MD 
simulations were performed with the program NAMD (23) using the all-atom 
CHARMM PARAM27 force field (24) and the TIP3P model of water (25). The H-
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peptide/PARP1 complexes were inserted into a cubic water box, with a minimal 
distance of 12 Å between any solute atom and the boundary of the box. Chloride and 
sodium ions were added to neutralize the system and approximate a salt concentration 
of 150 mM. The water molecules overlapping with the solute atoms or the ions were 
removed, if the distance between the water oxygen and any atom of the complex or 
any ion was smaller than 2.4 Å. Periodic boundary conditions were applied to avoid 
finite-size effects. Electrostatic interactions were calculated within a cutoff of 12 Å, 
while long-range electrostatic effects were taken into account by the particle mesh 
Ewald summation method (26). Van der Waals interactions were treated with the use 
of a switch function starting at 10 Å and turning off at 12 Å, which is the default of 
the all-atom CHARMM force field. The temperature was kept constant at 300 K by 
the Langevin temperature control with a damping coefficient of 5 ps-1, while the 
pressure was held constant at 1 atm by applying a pressure piston. Before the 
production runs, water molecules and ions were subjected to energy minimization for 
6000 steps, and a 1-ns equilibration with harmonic constraints applied to the positions 
of the C-alpha atoms. The covalent bonds involving hydrogen atoms were constrained 
by means of the SHAKE algorithm, and the dynamics were integrated with a time 
step of 2 fs. Snapshots were saved every 2 ps for trajectory analysis. Two MD runs 
with different initial distribution of velocities were carried out for each of the H4 
peptides AKRH and AKRHRKIL for a total simulation time of 150 ns for each 
peptide. Analysis of the trajectories was carried out with the programs CHARMM 
(27) and WORDOM (28). 
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Results 
PARP1 modifies core histones 
Recently, we reported the ADP-ribosylation of distinct lysine residues of PARP1 and 
PARP2 in cis (19,20). Since core histones were described earlier to be modified by 
PARP1 in vitro and in vivo ((16) and Suppl.Fig.1A,B), we set out to investigate which 
residues of H2A, H2B, H3 and H4 would be modified by PARP1, and possibly also 
by PARP2 in trans. First, human PARP1 and PARP2 were expressed and purified 
from insect cells using the baculovirus-system and were subsequently incubated with 
full-length histones isolated from calf thymus together with 100 nM radiolabeled 
NAD+. Although automodification of both PARP1 and PARP2 was easily detectable, 
only PARP1 displayed detectable trans-ADP-ribosylation of all four core histones, 
indicating a clear difference in the substrate specificity between PARP1 and PARP2 
(Fig. 1A). Similar experiments with bacterially expressed and purified single histone 
proteins revealed that, indeed, all four histones are modified by PARP1 (Fig. 1B).  
 
PARP1 mono- and poly(ADP-ribosyl)ates amino-terminal tails of core histone 
proteins covalently 
Earlier reports suggested that histones are mainly ADP-ribosylated at their amino-
terminal tails (13,29). To test whether PARP1-mediated ADP-ribosylation occurred at 
the amino-terminal tails or at the globular histone folds, we incubated the globular 
domains of histones H2B, H3 and H4 together with PARP1 and compared their ADP-
ribosylation to the full-length counterpart (Suppl.Fig. 2A). ADP-ribosylation of the 
globular domains was reduced in comparison to full-length histones, implying that 
indeed the amino-terminal tails are required for modification by PARP1. We then 
expressed the different histone tails as GST fusion proteins in bacteria and incubated 
them with purified PARP1 and radiolabeled NAD+. PARP1 was able to modify all 
four histone tails, whereas comparable PARP2-mediated ADP-ribosylation of histone 
tails was not detectable (Fig. 1C and Suppl.Fig. 2B). This finding suggests that the 
core histone tails are substrates specifically for PARP1 but not for PARP2 in vitro. 
Previous reports indicated that histones can interact with poly(ADP-ribose) non-
covalently via a PAR-binding motif (30). Since the tested histone tails we analyzed 
did not contain this motif, it is highly unlikely that the observed labeling represented 
non-covalently attached PAR. To exclude this notion experimentally, the histone tail 
fusion proteins were added to the ADP-ribosylation reaction either together with 
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PARP1 or after the enzymatic reaction had been stopped by addition of the PARP-
inhibitor 3-aminobenzamide (3AB). The addition of the histone tails after the reaction 
did not result in their modification (Fig. 1D, right panel), implying that the observed 
ADP-ribosylation is a covalent modification. To test whether the observed 
modification is an enzymatic reaction, the reaction was repeated in presence of the 
PARP-inhibitor PJ34. Increasing amounts of PJ34 abolished trans-ADP-ribosylation 
of the H2B tail, as well as automodification of PARP1 (Fig. 1E). Similar results were 
obtained with a second PARP-inhibitor, DAM-TIQ-A (Fig. 1E). Taken together these 
results indicate that PARP1 catalyze the covalent ADP-ribosylation of histone tails. 
PARP1 is a mono- and a poly(ADP-ribosyl) transferase (16). To determine 
whether the histone tails can be mono and/or poly(ADP-ribosyl)ated by PARP1, we 
incubated the histone tails with PARP1 in the presence of increasing amounts of 
NAD+. Poly(ADP-ribosyl)ation was determined by immunoblot analysis using an 
anti-PAR antibody, which recognizes only polymers of ADP-ribose (PAR). Both 
automodification of PARP1 and poly(ADP-ribosyl)ation of the histones were 
detected, indicating that PARP1 can attach long polymers of ADP-ribose onto histone 
tails (Fig. 1F). Notably, the length of poly(ADP-ribose) chains of the histones 
increased proportionally to the amounts of NAD+, which led to retarded migration of 
the modified proteins due to an increased molecular weight (Fig. 1F, filled asterisk). 
ADP-ribosylation was earlier described to occur on glutamates of H2B and H1 
(11,15). These findings were never directly attributed to PARP1 nor were they 
experimentally confirmed by mass spectrometry or amino acid substitutions. The 
PARP1-mediated ADP-ribosylation we describe here occurred on the basic amino-
terminal histone tails, most of which do not contain glutamates (Fig. 2A). One 
exception is the tail of histone H2B that contains one single glutamate. Mutation of 
this residue to alanine did not affect the levels of incorporated ADP-ribose onto the 
H2B tail by PARP1 (Suppl.Fig. 2C), suggesting that glutamates are dispensable and 
that additional residues can be efficiently ADP-ribosylated by PARP1 in trans. 
Furthermore, when we incubated poly-L-lysine or poly-L-glutamate with purified 
PARP1 and measured incorporated ADP-ribose, lysines but not glutamates were 
modified by PARP1 (Suppl.Fig. 2D). These findings are consistent with our previous 
reports (19,20) and provided additional evidences that lysines are likely the primary 
target sites for PARP1-mediated ADP-ribosylation. 
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Identification of ADP-ribose acceptor sites within histone tails 
As the amino-terminal histone tails are frequently targeted by a variety of post-
translational modifications with important physiological functions (6), we aimed at 
identifying the exact sites of PARP1-mediated ADP-ribosylation. To this end, we first 
generated a series of histone tail deletion mutants to test in ADP-ribosylation assays 
(Fig. 2A). Successive shortening of the histone tails invariably resulted in a loss of 
PARP1-mediated ADP-ribosylation and defined for each histone the region 
comprising putative ADP-ribose acceptor sites (Fig. 2B-E).  
 To directly identify the ADP-ribosylated amino acids within the histone tails 
by mass spectrometry, we used synthetic peptides covering the regions identified by 
our deletion strategy. We incubated these peptides with PARP1 in the presence of 
100-500 µM NAD+, stopped the reactions by addition of 3AB and subsequently 
treated the poly(ADP-ribosyl)ated peptides with ADP-ribosylhydrolase 3 (ARH3). 
ARH3 is known to possess PARG-like ADP-ribose glycohydrolase activity, which 
hydrolyzes ester linkages between ADP-ribose units (31). Since no negatively 
charged amino acids (E or D), which would allow the formation of an ester linkage, 
were present in the polypeptides (except for H2B E35), we rationalized that treatment 
of the modified polypeptides with ARH3 would leave the first ADP-ribose unit bound 
to the peptide. The ADP-ribosylated peptides were acetone precipitated and analyzed 
by liquid-chromatography coupled mass-spectrometry. In the presence of PARP1 and 
NAD+, the attachment of a single ADP-ribose unit resulted in a mass shift of 541 
Dalton (Fig. 3A-D). Fragmentation of ADP-ribosylated peptides with conventional 
CID (collision induced dissociation) fragmentation technique completely removed the 
ADP-ribose moiety from the peptides, not allowing the identification of specific 
amino acid acceptor sites (data not shown). In contrast, analysis of the modified 
peptides by ETD (electron transfer dissociation) resulted in an almost complete 
fragmentation of the multiple charged histone peptides, as indicated by the presence 
of c- and z- ions, which represent N- or C-terminal fragment ions, respectively (Fig. 
3A-D, Suppl.Fig. 2E). Fragmentation of the mono(ADP-ribosyl)ated H2A peptide 
revealed specific ADP-ribosylation of K13, while H2B was mainly ADP-ribosylated 
at K30 (Fig. 3A,B). H3 was ADP-ribosylated at K27 and K37 (Fig. 3C and Suppl.Fig. 
2E). For H4, mass spectrometric analysis identified K16 to be ADP-ribosylated by 
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PARP1 (Fig. 3D). Control reactions performed in the presence of 500 µM NAD+ but 
without PARP1 or in the presence of 500 µM ADP-ribose and PARP1 did not result 
in specific ADP-ribosylation (data not shown). The identified sites of PARP1-
mediated enzymatic ADP-ribosylation represent two known sites of frequent histone 
modification (H3K27 and H4K16) as well as novel modification sites (H2AK13, 
H2BK30 and H3K37). To verify the mass spectrometric data for one histone, the H4 
tail was mutated at K16 to alanine and tested for ADP-ribosylation by PARP1. The 
mutated H4 tail showed severely reduced ADP-ribosylation in comparison to the 
wild-type H4 tail (Fig. 3E, filled asterisk). The reduction of ADP-ribosylation was not 
due to a reduced interaction of PARP1 with the mutated H4 tail, since wild-type and 
mutated histone tail fusion proteins were able to interact with PARP1 to comparable 
levels (Fig. 3F).  
 
Modeling of the histone H4 tail reveals that R17 is critical for the interaction 
with the catalytic domain of PARP1 
In order to test computationally, whether the tail of H4 could enter the catalytic cleft 
of PARP1, automatic docking followed by explicit solvent molecular dynamics (MD) 
simulations were performed with the crystal structure from chicken PARP1 (PDB ID: 
1A26), which uses the sequence numbering of human PARP1 (see Methods). The MD 
simulations indicate that the H4 tetrapeptide segment AKRH (aa 15-18) binds in an 
extended conformation to the catalytic domain of PARP1 (Fig. 4A,B). Two stable salt 
bridges are observed in all MD runs: between H4K16 and PARP1 Glu988 in the 
catalytic cleft, and between H4R17 and PARP1 Glu756 (Asp756 in human PARP1) 
on a loop at the entrance of the cleft. These intermolecular salt bridges lock H4 into 
the catalytic domain of PARP1 like two stretched arms holding two points far away 
from each other. In all MD runs, a single water molecule inserts between the amino 
group of K16 and the carboxy group of Glu988 in the first 15 ns and remains between 
these two charged groups until the end of the MD simulations of the tetrapeptide 
(Suppl.Fig. 3). This water molecule occupies the same position as the water molecule 
that is close to Glu988 in the X-ray structure of PARP1 (water 37 in PDB code 
1A26). There are two additional side chains interactions: a stacking interaction 
between the imidazole of H18 and the amide group of Gln759 is almost always 
present in all MD runs, while the hydrogen bond between the side chains of R19 and 
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Asn906 is not very stable. In contrast to the aforementioned intermolecular salt 
bridges and hydrogen bonds, the K20 side chain is always exposed to solvent and 
very flexible. Furthermore, the backbone polar groups of the histone do not seem to 
be involved in hydrogen bonds with PARP1. Importantly, in all MD simulations both 
the N-terminal and C-terminal methyl groups point towards the solvent, which would 
allow the rest of the H4 polypeptide chain to position itself close to the surface of 
PARP1 without steric clashes. Moreover, the MD runs with the H4 tetra- and 
octapeptide (aa 15-22) converge towards a common extended structure of the AKRH 
segment with the same side chain interactions. The convergence of multiple MD 
simulations and the agreement with the experimental results indicate that the binding 
mode obtained by docking and explicit water MD is reliable. To gain insight in the 
putative initiation step of ADP-ribosylation, the 10 ns snapshot of the MD simulation 
with the H4 tetrapeptide was used for docking NAD+ into the donor site as previously 
published (32,33). Before docking, the nicotinamide was manually removed (Fig. 
4C), which mimics the NADase activity of PARP1 and creates a reactive C1-atom of 
the ADP-ribose that is suggested to react with the substrate amino acid (19,34,35). 
Interestingly, the C1-atom of the ADP-ribose is only 3.7 Å away from the !-amino 
group of H4K16 and 7.8 Å from the !-amino group of Lys903. Moreover, the distance 
between the catalytic active Glu988 carboxy group and the !-amino group of H4K16 
is only 3.0 Å, which would potentially allow covalent ADP-ribosylation of H4K16 
(Fig. 4C). 
To test experimentally whether an arginine close to H4K16 is required for the 
interaction with PARP1, we mutated R17 (H4R17A) and analyzed the association 
with and the modification by PARP1. GST-pulldown experiments with recombinant 
PARP1 revealed that the interaction between PARP1 and the mutated H4 tail fusion 
protein was reduced (Fig. 4D), as well as its ADP-ribosylation by PARP1 (Fig. 4E). 
In agreement with the MD simulation and the mass spectrometry data, an 
H4K16A/R17A double mutant was completely defective for PARP1-mediated ADP-
ribosylation (Fig. 4F). Since H4R17 was suggested by molecular modeling to interact 
with Asp756 of PARP1, we mutated Asp756 into a lysine (which is the corresponding 
amino acid at this position in PARP2) and tested this mutant for its ADP-ribosylation 
properties. The PARP1 mutant exhibited no defect in auto(ADP-ribosyl)ation (Suppl. 
Fig. 2F), indicating that Asp756 is not essential for automodification. This is 
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consistent with the fact that also PARP2 is able to modify itself, although it contains a 
lysine at the corresponding position. Interestingly, however, the PARP1 mutant was 
impaired in trans-ADP-ribosylation of full-length histones (Fig. 4G) and in the 
labeling of the H4 (1-22) peptide (Supp. Fig. 1G), confirming the importance of this 
residue for stabilization of the peptide in the catalytic cleft and subsequent trans(ADP-
ribosyl)ation of H4.  
 
Acetylation of K16 inhibits ADP-ribosylation of histone H4  
Acetylation of H4K16 occurs frequently in eukaryotic cells and has been correlated 
with chromatin decompaction (6). If H4K16 was indeed an acceptor site for PARP1-
mediated ADP-ribosylation, acetylation at that site should impair ADP-ribosylation. 
In order to test this hypothesis, we employed a H4 peptide (aa 1-22) chemically 
acetylated at K16. LC-coupled mass spectrometry of the H4K16ac peptide revealed 
that PARP1 was not any longer able to induce ADP-ribosylation of the acetylated 
peptide above background (Fig. 5A). Consistent with this result, PARP1 mediated 
ADP-ribosylation of both peptides (unmodified and acetylated) with radiolabeled 
NAD+, followed by purification over a microvolume-C18 reversed phase column and 
subsequent measurement of incorporated radiolabeled NAD+, provided evidence that 
ADP-ribosylation of the acetylated peptide was severely reduced (Fig. 5B). These 
results confirm that H4K16 is modified by PARP1 and show that acetylation of K16 
severely impairs ADP-ribosylation of the H4 peptide. Together, our results led to the 
identification of ADP-ribose acceptor sites within the amino-terminal tails of the four 
core histones (Fig. 5C) and imply important cross-talks with other histone 
modifications such as acetylation or methylation. 
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Discussion 
Here, we provide evidence that PARP1 covalently modifies the tails of all four core 
histones. We identified H2AK13, H2BK30, H3K27, H3K37, and H4K16 as specific 
target sites for PARP1-mediated ADP-ribosylation. Our conclusions are based on 
several observations: (i) mass spectrometric analyses of PARP1-mediated ADP-
ribosylated peptides, (ii) loss of function experiments by site directed mutagenesis of 
the putative acceptor sites in recombinant histone tail fusion proteins, (iii) cross-talk 
of acetylation and ADP-ribosylation at the identified acceptor site in H4 and, finally, 
(iv) prediction of the interaction between the histone H4 tail and PARP1 by molecular 
dynamics and subsequent confirmation with mutated proteins. 
 Nearly 20 years ago, ADP-ribose acceptor sites were found in histones by 
biochemical approaches. Several laboratories identified glutamic acid residues in 
histone H1 and histone H2B to be modified when they incubated chromatin from rat 
liver with radioactive NAD+ (11,13-15). At that time, no other PARP family member 
had been identified yet, and no knockout- or knockdown-system was available. Thus, 
it is possible that PARP1, other PARP-family members or even unrelated NAD+ 
consuming enzymes were responsible for the modification at the identified 
glutamates. In fact, we could show here by mutational analyses, that E2 of H2B is 
dispensable for PARP1-mediated ADP-ribosylation and that additional amino acid 
residues are acceptors for ADP-ribose moieties. Consistent with this, we identify 
lysines in the amino terminal histone tails and in particular lysine 13 of H2A, lysine 
30 of H2B, lysines 27 and 37 of histone H3, as well as lysine 16 of histone H4 as 
target sites for enzymatic ADP-ribosylation by PARP1, both by mass spectrometry 
and amino acid substitution. Therefore, we propose the ADP-ribosylation of the !-
amino group of lysines by PARP1 as a new canonical histone tail modification. 
 Remarkably, explicit solvent water MD revealed that the tetra- and 
octapeptides of H4 interact strongly with specific amino acid side chains of the 
catalytic cleft of PARP1, suggesting that specific binding of a relatively short segment 
of H4 is sufficient to allow poly(ADP-ribosyl)ation of the histone tail. The positively 
charged amino acid at the +1 position of the ADP-ribosylated residue formed a salt 
bridge with Glu756 of chicken PARP1, which corresponds to Asp756 in human 
PARP1. In contrast, the corresponding amino acid in PARP2 is a lysine at position 
312. Although the catalytic domains between PARP1 and PARP2 are highly similar 
(18), the substrate specificity of those enzymes might be regulated by subtle 
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differences in the catalytic cleft. This could explain why PARP2 does not modify 
histones to a detectable extent at least in vitro (Fig. 1A, C and Suppl.Fig. 2B). 
 Application of novel mass spectrometry techniques allowed us to identify 
distinct amino acids as acceptors of ADP-ribose. We took advantage of the electron 
transfer dissociation technique (36), which allows the fragmentation of highly charged 
peptides, leaving most post-translational modifications intact. Recent publications 
describe the technical basis for the fragmentation of chemically ADP-ribosylated 
peptides by electron capture dissociation (ECD) (37) and the closely related electron 
transfer dissociation (ETD) (38). It is noteworthy, that, in contrast to other reports, we 
observed partial fragmentation of the ADP-ribose at the phosphodiester bond by 
application of ETD, as revealed by the presence of a (m/z 348) ion. However, 
conventional collision induced dissociation (CID) mass spectrometry of ADP-
ribosylated H4 peptide did not reveal any ADP-ribose acceptor sites, since the ADP-
ribose was cleaved off from the peptide during fragmentation. The commonly used 
CID, instead of ETD, might thus explain why numerous efforts to identify ADP-
ribosylated residues failed in the past. Consequently, we would strongly recommend 
ETD as standard technique to detect ADP-ribosylated peptides. Of note, a previous 
study employing CID failed to detect ADP-ribosylated lysine residues in the catalytic 
PARP1 mutant E988Q (39). In summary, ETD can be expected to facilitate future 
investigations on ADP-ribosylated peptides, opening new opportunities to screen for 
ADP-ribosylated residues in a systems-biology setup. 
 Since poly(ADP-ribosyl)ated peptides cannot be detected by MS and PARP1 
mainly attaches poly(ADP-ribose) to target proteins, we removed the poly(ADP-
ribose) with ARH3, which degrades poly(ADP-ribose). However, this treatment was 
rather inefficient (data not shown), which could partly explain the observed low 
mono(ADP-ribosyl)ation of the histone peptides. Moreover, we cannot exclude that 
PARP1 modifies additional residues, which were not identified by these mass 
spectrometric analyses. 
 Our data provide strong evidence that PARP1-mediated ADP-ribosylation of 
histones occurs as post-translational modification at distinct lysine residues within the 
amino-terminal basic tails. From a chemical perspective, modification of a lysine 
residue by ADP-ribose results in an unstable Schiff base, which can undergo an 
Amadori rearrangement to form a stable ketoamine (19,40). It will be interesting to 
investigate whether histone lysine ADP-ribosylation can be reversed by a previously 
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identified but still poorly characterized ADP-ribosyl protein lyase (41). Since the 
attachment of ADP-ribose not only neutralizes the positive charge of the amino acid 
side chain, but instead reverses it into a negative charge, the functional consequences 
of lysine ADP-ribosylation can be assumed to be even more drastic than other 
modifications, such as acetylation. Therefore, the possible effects on chromatin 
architecture, histone dynamics, histone degradation, and histone variant incorporation 
may be dramatic. Possibly, ADP-ribosylation of histones interferes with other post-
translational modifications of the histone tails. For example, H3K27 is methylated by 
EZH2 (enhancer of zeste homolog 2), which is in the polycomb group complex that is 
involved in maintenance of the inactive X-chromosome (42). Interestingly, PARP1 
was demonstrated to participate in the maintenance of X-chromosome silencing as 
well (43). On the other hand, the amino-terminal tail of histone H4 was shown to be 
required for chromatin fiber formation, since the positively charged stretch between 
K16 and K20 makes internucleosomal contacts to two acidic patches on the carboxy-
terminal "-helices of histone H2A (44). In addition to its function for chromatin 
topology, the stretch between K16 and K20 is required for the interaction with various 
non-histone modulators. For example, the ISWI-containing ATP dependent chromatin 
remodeler ACF solely engages histone H4, but is repelled, if H4K16 is acetylated 
(45,46). Furthermore, the chromatin remodeler Alc1 was shown to require the K16 to 
K20 stretch of H4 for its activity (47). Interestingly, recent reports provide evidence 
that the ATPase activity of Alc1 is highly stimulated by binding to poly(ADP-
ribosyl)ated PARP1 (47,48). Whether ADP-ribosylated H4 would activate Alc1, 
remains to be investigated. Another intriguing possibility of how histone tail ADP-
ribosylation could affect chromatin function is implied by a recent study showing that 
macrodomain-containing histone variants specifically bind to poly(ADP-ribose) 
generated after DNA damage (49). Using biochemical, crystallographic and state-of-
the-art imaging techniques, it was shown that macroH2A1.1 senses PARP1 activation 
and directly binds poly(ADP-ribose) to cause a transient compaction of the chromatin. 
It will be interesting to investigate whether macrodomains preferentially bind to 
automodified PARP1 or also function as “readers” of poly(ADP-ribosyl)ated histone 
tails. 
 Taken together, the here presented work sheds new light on a well known but 
neglected histone modification and builds the basis for future investigations exploring 
the function of histone lysine ADP-ribosylation in chromatin dynamics, transcription, 
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DNA repair signaling and other nuclear processes influenced by histone 
modifications. 
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Figure Legends  
Figure 1: PARP1 covalently modifies all four core histone tails 
(A) PARP1 trans-ADP-ribosylates histones isolated from calf thymus. 10 pmol 
recombinant PARP1 or PARP2 were incubated for 15 min (PARP1) or 30 min 
(PARP2) at 30°C with 5 pmol EcoRI-linker DNA, 100 nM radiolabeled NAD+ and 20 
µg extracted histones from calf thymus. The reaction was stopped by addition of 
SDS-lysis buffer and the proteins were resolved on a 10-20% SDS-PAGE gradient 
gel. The gel was stained with Coomassie-R250 and incorporated 32P was visualized 
by autoradiography. (B) Recombinant expressed and purified histones (3 µg) were 
ADP-ribosylated by PARP1 as in Figure 1A. (C) 1.5 µg of each purified GST-histone 
tail were used in PARP1 or PARP2 mediated trans-ADP-ribosylation reactions for 5 
minutes at 30°C. (D) 1.5 µg of each purified GST-histone tail were used in PARP1 
mediated trans-ADP-ribosylation reactions for 5 minutes at 30°C. Histone tails were 
either included during the reaction (pre) or added after the reaction had been stopped 
with a 100-fold excess of 3-aminobenzamide over radiolabeled NAD+ (post) to 
exclude non-covalent interaction of the histone tails with PAR. (E) Trans-ADP-
ribosylation of the H2B tail is inhibited by the PARP-inhibitors PJ34 (0.01 µM-100 
µM) and DAM-TIQ-A (10 µM). (F) GST-histones were incubated with PARP1, 
EcoRI linker and increasing concentrations of NAD+ (0, 10, 100, 400 µM) for 10 min 
at 30°C. Poly(ADP-ribose) formation was assessed through western blotting with 
anti-PAR (LP-96-10) antibody. Unmodified GST-histone tails are marked by an 
empty asterisk, PARylated GST-histone tails are marked by a filled asterisk.  
 
Figure 2: Confining the regions of putative ADP-ribose acceptor sites 
(A)  Schematic representation of the deletion strategy for GST-histone tails to identify 
the minimal ADP-ribosylated domain. (B-E) Trans-ADP-ribosylation of the indicated 
GST-histone deletion mutants by PARP1 with 100 nM 32P-NAD+.  
 
Figure 3: Mass spectrometric analysis of ADP-ribosylated histone peptides 
(A) Extracted ion chromatogram of the biotin tagged H2A (aa 3-23) peptide incubated 
with 500 µM NAD+ and PARP1. The precursor masses of unmodified H2A peptide 
(2395.34 Da) and ADP-ribosylated H2A peptide (2936.40 Da) were plotted in a range 
of 10 ppm over time. ETD fragment spectrum of quintuple charged precursor mass of 
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ADP-ribosylated H2A peptide (638.51 m/z) at K13, as indicated by the sequence plot. 
The spectrum shows next to the 2 major peaks of unfragmented charge reduced 
precursor masses (M+5H)n+ an almost complete series of N-terminal and C-terminal 
fragment ions (c-ions, z-ions, respectively). (B) Extracted ion chromatogram of the 
biotin tagged H2B (aa 18-37) peptide incubated with 500 µM NAD+ and PARP1 as in 
(A). ETD fragment spectrum of ADP-ribosylated H2B peptide (797.89 m/z) at K30, 
indicated by the sequence plot. (C) Extracted ion chromatogram of the biotin tagged 
H3 (aa 23-42) peptide incubated with PARP1 as in (A). ETD fragment spectrum of 
ADP-ribosylated H3 peptide (590.29 m/z) at K27, indicated by the sequence plot. (D) 
Extracted ion chromatogram of the biotin tagged H4 (aa 1-22) peptide incubated with 
100 µM NAD+ and PARP1. ETD fragment spectrum of ADP-ribosylated H4 peptide 
(621.30 m/z) at K16, as indicated by the sequence plot. (E) Trans-ADP-ribosylation 
of the GST-H4 histone tail wild-type or K16A mutant by PARP1. (F) GST-pulldown 
of wild-type and mutated GST-histone H4 tails with recombinant PARP1. The GST-
histone tails are marked by an asterisk. 
 
Figure 4: Histone H4 interacts with PARP1 by salt bridges with acidic residues 
in the catalytic domain 
(A) Representative snapshot of the binding mode saved after 10 nanoseconds (ns) MD 
simulation of the H4 tetrapeptide AKRH. (B) Enlarged view of the catalytic cleft for 
the same snapshot as in (A). Amino acids in close proximity of the H4 peptide are 
highlighted. PARP1 and the H4 tetrapeptide are shown in surface render and sticks, 
respectively. The surface is colored according to atomic elements with carbon, 
oxygen and nitrogen in green, red, and blue, respectively. Carbon atoms of the H4 
tetrapeptide are in cyan. (C) ADP-ribose was docked into the donor-site of PARP1 
catalytic domain after 10 ns MD simulation of the H4 tetrapeptide. Amino acids in 
close proximity of the H4 peptide are highlighted. The orientation is rotated by about 
180°C with respect to (A,B). (D,) GST-pulldown of wild-type and mutated GST-
histone H4 tail with recombinant PARP1 and subsequent western blot with anti-
PARP1 antibody. GST-histone tails are indicated by an asterisk. (E,F) Trans-ADP-
ribosylation of wild-type and mutated GST-H4 tails with PARP1 and radiolabeled 
NAD+. Coomassie stains of the input and autoradiographies are shown. (G) Trans-
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ADP-ribosylation of calf-thymus extracted histones by PARP1 wild-type or PARP1 
D756K mutant as in Fig. 1A. 
 
Figure 5: ADP-ribosylation of the H4 peptide is impaired by H4K16 acetylation  
(A) Elution profile of biotinylated H4 peptide (aa 1-22) and biotinylated H4K16ac 
peptide (aa 1-22) incubated with 100 µM NAD+ for 15 min without PARP1 (- 
PARP1) or in the presence of PARP1 (+ PARP1) and subsequent ARH3 treatment. 
Acetone precipitated peptides were run on a LC-MS/MS with a C18-reversed phase 
column and subsequent detection by mass-spectrometry. (B) Histone H4 (aa 1-22) and 
acetylated H4K16ac (1-22) peptides were ADP-ribosylated with PARP1 for 15 min at 
30°C with 100 nM 32P-NAD+. The peptides were purified by microvolume-C18 
reversed phase columns, eluted into scintillation liquid and counted for incorporated 
32P. Relative increase of counts per minutes was calculated over background (peptides 
added after termination of the reaction by 3AB). (C) Overview of the identified ADP-
ribose acceptor sites within the amino-terminal core histone tails. 
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Supplementary Methods 
 
Cell culture, transfection of siRNA and overexpression of PARP1 
HEK293T cells were grown in DMEM Glutamax-1 (Invitrogen), supplemented with 10% 
(v/v) fetal calf serum (Invitrogen) and 50 units/ml penicillin and 50 µg/ml streptomycin 
(Sigma). Cells were grown in 5% CO2 and 37°C in a humidified incubator. HEK293T 
cells were transfected with RNAi-max (Invitrogen) and siRNA directed against PARP1 
(Qiagen, Cat.No. S102662989) or control siRNA (Qiagen, Cat.No. S103650318) for 48 
hours. Overexpression of PARP1 was performed by transfection of HEK293T cells by 
standard Calcium-Phosphate precipitation method with a pcDNA3-HA-PARP1 
expression vector or an empty vector control, respectively. 8 hours after transfection the 
medium was replaced and the cells were grown for another 20 hours before they were 
harvested. 
 
ADP-ribosylation of isolated nuclei 
Nuclei were isolated from 5x 10
6
 HEK293T cells by the addition of cold hypotonic lysis 
buffer (5 mM HEPES pH 7.4, 0.5% NP-40, 85 mM KCl, 1 µg/ul Pepstatin, Leupetin, 
Bestatin). After 2 minutes of incubation, the nuclei were centrifuged for 4 min at 7000g 
and washed twice with suspension buffer (33.3 mM Tris-HCl pH 7.8, 40 mM MgCl2, 1 
µg/ul Pepstatin, Leupetin, Bestatin). The pellet was resuspended in permeabilization 
buffer (38.3 mM Tris-HCl pH 7.8, 42.1 mM MgCl2, 0.53 mM EDTA, 13.9 mM !-
Mercaptoethanol, 1 µg/ul Pepstatin, Leupetin, Bestatin), supplemented with 400 µM 
etheno-NAD
+
 (Sigma Aldrich) or 4 mM PJ34 (Enzo Life Science) and incubated for 20 
min at 37°C at 900 rpm in a rotator. After centrifugation the pellet was resuspended in 
SDS-lysis buffer and run on a 18% SDS-PAGE. Western blotting was performed with 
anti Ig4 antibody hybridoma serum (kindly provided by Dr. R. Santella, Columbia 
University, USA) in a vacuum blot apparatus (Millipore SNAP i.d). 
 
 
 
 
Supplementary Figures 
 
Supplementary Figure 1: 
PARP1 poly(ADP-ribosyl)ates chromatin associated histones. (A) HEK293T cells were 
depleted of PARP1 and nuclei were prepared. The nuclei were incubated with 400 µM 
etheno-NAD
+
 at 37°C for 20 min and lysed in SDS-lysis buffer. Western blotting was 
performed with the Ig4 antibody, which specifically recognizes the etheno-group of 
NAD
+
.
 
(B) HEK293T cells were transiently transfected with HA-PARP1 (ov. PARP1) or 
with an empty vector (control). Nuclei were prepared and incubated with 400 µM etheno-
NAD
+
 in presence or absence of the PARP-Inhibitor PJ34. 
 
Supplementary Figure 2: 
(A) Trans-ADP-ribosylation of histone tails by PARP1. 1.5 µg of full-length and 
truncated histones were incubated with 10 pmol PARP1 and 100 nM 
32
P-NAD
+
 for 15 
min at 30°C. His-tagged H2B (36-122) was generated by PCR and cloned into pET3a 
with NdeI and BamHI restriction enzymes. The protein was expressed in inclusion 
bodies, solubilized, purified by a nickel-column and dialyzed against water. The other 
histones were expressed and purified as in Luger K. et al, 1997, JMB, 272, 301-311. (B) 
Identical to Fig. 1C of the main manuscript. The automodification of PARP2 was 
adjusted to the automodification of PARP1 by ImageQuant-Software. (C) Trans-ADP-
ribosylation of H2B is not impaired in an H2B E2A mutant, in which the only glutamic 
acid residue is substituted by an alanine. Shown are autoradiographs and Coomassie 
stained gels. (D) Poly-L-lysine but not poly-L-glutamate are modified by hPARP1. Poly-
L-amino acids were coupled onto cyanogen-bromide activated agarose beads over night 
as suggested by the provider (Sigma-Aldrich). Excess poly-L-amino acids were washed 
away and unoccupied reactive sites were blocked over night. The beads were washed and 
equilibrated in PARP1 reaction buffer. Reactions were performed for 5 minutes at 30°C 
in the presence of 100 nM radiolabeled NAD
+
. The beads were washed 3 times in PARP1 
reaction buffer containing 500 mM NaCl before scintillation counts in two different 
channels were determined. (E) Extracted ion chromatogram of the biotin tagged H3 (23-
42) peptide, ADP-ribosylated by PARP1. ETD fragment spectrum of ADP-ribosylated 
H3 peptide (590.29 m/z) at K37, indicated by the sequence plot. (F) Automodification of 
wild-type PARP1 and PARP1 D756K mutant for 10 min at 30°C in presence of 
activating DNA (EcoRI-linker) and 100 nM 
32
P-NAD
+
. Shown is an autoradiography and 
the coomassie stained gel. (G) Histone H4 (aa 1-22) peptide was ADP-ribosylated with 
PARP1 or PARP1 D756K mutant for 15 min at 30°C with 100 nM 
32
P-NAD
+
. The 
peptides were purified by microvolume-C18 reversed phase columns, eluted into 
scintillation liquid and counted for incorporated 
32
P. Relative increase of counts per 
minutes was calculated over background (peptides added after termination of the reaction 
by 3AB) and the counts obtained for wild-type PARP1 were set to 100. 
 
Supplementary Figure 3: 
Time evolution of intermolecular salt bridges and side chain dihedral angles of PARP1 
Tyrosine residues in the catalytic cleft. 
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